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Abstract 
 
Simplification of disclosures is widely regarded as an important goal and is 
increasingly mandated in a variety of areas. In the area of data privacy, 
lawmakers and interest groups developed “Best Practices” techniques to help 
consumers understand how firms collect and use personal information. 
Commentators have even advocated going a step further and using simpler 
disclosures—warning boxes that alert consumers to the least expected 
elements. But do these techniques succeed in better informing consumers or 
preventing unwise behavior? To answer this question, we engaged a leading 
market research firm to conduct a survey on risky sexual behaviors while 
randomizing the format of the privacy disclosures provided to the 
respondents. The results of the experiment suggest that best practices 
simplification techniques and warning boxes do not have the intended 
effects. We find little or no change in respondents’: (1) comprehension of the 
disclosure; (2) willingness to share personal information; and (3) 
expectations about their rights. Our results challenge the wisdom of focusing 
regulatory effort on simplifying disclosures. 
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1. INTRODUCTION 
 
Mandated disclosure is the most commonly used regulatory device in privacy 
protection. Disclosure seems like a sensible tool because transparency provides a simple 
and proportional solution to the underlying problem. If people unwisely surrender much 
of their personal information because they are unaware that it will be broadly used and 
widely shared, then the solution is to make them aware by requiring firms to disclose the 
information. With the knowledge that disclosures afford them, people can then make 
wiser information sharing choices. Based on this theory, laws regulating financial and 
medical services, for example, require privacy disclosures to be prominent and to provide 
specific information that is deemed relevant to consumer decisions.1  
But despite the allure and wide embrace of “transparency” as a guiding principle, 
it has proven hard to accomplish successfully. Firms, of course, usually comply with the 
letter of “shine the light” laws and post privacy notices with magnificent detail. But 
consumers remain largely ignorant of the specific details of the notices and continue to 
divulge loads of personal information. And even if consumers wanted to inform 
themselves, they could not feasibly make informed data sharing choices. According to 
one estimate, the average person encounters so many privacy disclosures every year, that 
it would take 76 days to read them, and the lost time would cost the economy $781 
billion (McDonald & Cranor 2008).  
Privacy disclosures’ failure to meaningfully inform consumers poses a challenge: 
could the formats be reengineered to be more useful? If consumers care about privacy but 
don’t read the disclosures because they are poorly drafted and overloaded, the solution 
seems inevitable: simplification. If a disclosure is too long, shorten it. It it’s too technical, 
make it more user-friendly. If it’s poorly presented, improve the formatting.  
Although it may sound obvious that complex privacy disclosures should be 
simplified, exactly how this should be done is not obvious. Privacy disclosures are 
complex because firms collect many types of personal data and use it in numerous ways. 
Should people be given less than full information, to help them focus better attention on 
the most essential ingredients? Or should people be given all the information, but in a 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1  See, e.g., The Gramm-Leach-Bliley Act, 12 C.F.R. § 1016.5; Health Insurance Portability and 
Accountability Act (HIPAA) § 164.520.  
 Electronic copy available at: http://ssrn.com/abstract=2711474 
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standardized format? In search for pragmatic ways to present privacy practices more 
effectively, several simplification strategies have risen to the fore. 
One simplification strategy focuses on improving the formatting and organization 
of disclosures. In the privacy area, it is part of a protocol known as “Best Practices.” 
Proposed by lawmakers, advocacy groups and privacy experts, Best Practices are an 
informal “code of conduct” focusing on “enhanced transparency,” to help consumers to 
“meaningfully” compare and choose on the basis of, among other things, privacy 
considerations.2 Although some of the Best Practices address the substance of privacy 
practices (for example, imploring firms not to collect unnecessary information), the bulk 
of the Best Practices deal with formal properties of disclosures (for example, telling firms 
how to present information clearly and succinctly).  
A second simplification strategy is even more ambitious. It looks to the perceived 
(although debatable) success of disclosure tools like the Nutrition Data boxes on food 
packaging as a model for effective disclosure. The gist of this solution is to aggressively 
trim down the disclosure to only a few essential facts—those least expected by 
consumers—and present them in a standardized, non-technical, and easily comparable 
format (Kelley et al. 2009; Ayres and Schwartz 2014). 
Both academics and policy makers have suggested that these strategies would 
improve consumers’ comprehension and behavior. For example, a study solicited by 
government found, based largely on interviews, that “good design techniques, combined 
with the simplified content, helped consumers better understand the information.”3 
Similarly, Ayres and Schwartz (2014, p. 605) believe that the warning box method 
“might efficiently correct the most serious forms of consumer optimism.” But despite 
these claims about the benefits of simplification strategies, it is not known whether these 
simplifications actually change behavior.  
In this paper, we present the results of a survey experiment that we designed to 
help answer this question. The experiment focuses on privacy disclosures, but its design 
is generic enough to at least suggest a more general lesson about the simplification 
paradigm. We engaged a leading market research firm to field the experiment and told 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2 See, e.g., Short Form Notice Code of Conduct to Promote Transparency in Mobile App Practices (NTISA 
Redline Draft, 2013), p. 1. 
3 Evolution of a Prototype Financial Privacy Notice xi (Kleimann Communication Group, 2006) 
	   4 
the respondents (deceptively) that they were participating in a survey on risky sexual 
practices that would be used to help develop a commercial mobile application that 
improves the utility of existing dating services. During the survey, the respondents were 
asked a host of questions about their sexual behavior and to provide several key pieces of 
identifying information (topics that are both known to elicit privacy concerns).  
The experimental treatment was the privacy disclosure that the respondents 
received at the beginning of the survey. Before the respondents were asked any questions, 
they were presented with a data privacy disclosure that listed all the ways that their 
personal information would be collected and shared. The disclosures were intended to 
arouse discomfort among the respondent, and they covered exactly the same topics and 
adopted exactly the same substantive policies. For example, all of the disclosures said 
that we share the information about their sexual behavior with commercial parties and 
that we do not monitor how those parties secure the data. Our experiment was thus not 
about the substance of the privacy disclosures, but instead about the impact of the 
disclosures’ formal properties. Specifically, we randomly presented the respondents  
disclosures that employed different set of the Best Practices that are most commonly 
found in guides for developing model disclosures.  
After exposing respondents to one of these disclosures, our survey proceeded to 
ask questions designed to test whether the formal properties of the disclosure influenced 
behavior in three ways. First, we measured respondents’ comprehension of the disclosure 
by counting the amount of time they spent on the disclosure screen and by asking a series 
of comprehension questions. Second, we measured respondents’ willingness to disclose 
sensitive personal information by asking questions about risky sexual practices and by 
requesting identifying information. Third, we measured respondents’ expectations about 
their privacy rights by asking whether they believed they had legal recourses if we 
violated our privacy policy and whether they were satisfied about the steps taken to 
protect their privacy. In each of these three tests our results were consistent: altering the 
formal properties of the privacy disclosures had essentially no effect on respondents’ 
comprehension of our disclosure, willingness to disclose information, or expectations 
about their privacy rights.  
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Additionally, we conducted a test to examine the effect of a more radical 
simplification technique proposed by Ayres and Schwartz (2014) and others. To do so, 
we conducted a separate survey that asked respondents to rank the gravity of our privacy 
practices. We then used a treatment that was simply a “Warning Label” that only 
specified the five worst, or least expected, privacy practices. Here, too, we found no 
meaningful effects. Perhaps struck by the novel format of a warning label, respondents 
spent more time eyeballing it (although hardly enough to digest it), but they then 
proceeded to behave in a way indistinguishable from their conduct under any of the more 
cluttered disclosures. 
Our findings contrast sharply with the more optimistic tone suggested by prior 
experimental exercises. For example, Kelley et al. (2010) presented people with 
simplified and full-text versions of privacy disclosures and concluded that a standardized 
short table formats “significantly outperform” the full-text formats. Similar findings were 
documented in testing of simplified mortgage forms.4 But these results should be taken 
with caution. They show that if people are sufficiently focused on the cognitive task of 
reading and learning about a specific issue, going back and forth to reread the text, their 
understanding increases by good presentation of the materials. By contrast, our findings 
suggest that when people are engaged in a real world task that focuses their attention 
elsewhere, the incidental presentation of simplified disclosures does not affect their 
behavior. 
Before proceeding, it is important to note a procedure we followed to enhance the 
credibility of our study. Both of us entered this project skeptical about the value of 
disclosure, even when simplified. We were concerned that if the results would turn out 
consistent with our priors, as indeed they did, our readers would view them with 
(justified) suspicion. After all, how often do scholars publish empirical results that 
conflict with their own previously published predictions and conjectures? Thus, as a form 
of pre-commitment, we circulated a draft with the design of our experiment prior to 
actually conducting the survey and thus before we knew the results. Subsequently, based 
on comments by participants in a conference to whom we presented the results, we reran 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 See, e.g., Know Before You Owe: Evolution of the TILA-RESPA Disclosures (Report Presented to 
the Consumer Financial Protection Bureau, July 9, 2012), available at 
http://files.consumerfinance.gov/f/201207_cfpb_report_tila-respa-testing.pdf. 
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another round of the experiment, tweaked to further induce subjects to act in caution and 
to notice the disclosures. The results of both rounds of the experiment were very similar, 
and for brevity we present here only the final round.5  
Our paper proceeds as follows. We begin by providing a brief survey of 
disclosure simplification techniques and then explain the survey experiment we designed 
to test whether these techniques influence behavior. We then present the primary results 
of our experiment. After doing so, we present results of a “warning label” style privacy 
disclosure. Finally, we conclude by briefly discussing the implications of our results for 
future research and policy.  
 
2. RESEARCH DESIGN 
2.1. Best Practices 
There is a widespread consensus among privacy experts, lawmakers, and 
advocates that an important component of a firm’s data privacy practices is providing a 
clear disclosure of their policies. This consensus is reflected in the Consumer Privacy Bill 
of Rights released by the White House that declared “Consumers have a right to easily 
understandable and accessible information about privacy and security practices.”6 The 
Federal Trade Commission (FTC) has deemed accessible transparency to be a “baseline 
principle,” and instructed firms “to present choices to consumers in a prominent, relevant, 
and easily accessible place . . . and undertake consumer education efforts to improve 
consumers’ understanding of how companies collect, use, and share their data.”7 In its 
widely accepted Fair Information Practice Principles, the FTC requires privacy 
disclosures to be “clear and conspicuous,” which it defines as “a disclosure be readily 
understandable, likely will communicate effectively the information needed by 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
5 The results of our pilot survey are presented in this paper’s Supplemental Materials. The unpublished first 
round of the experiment is posted online as 'Best Practices' in the Design of Privacy Disclosures: An 
Experimental Test, at http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2670115. 
6 Consumer Data Privacy in a Networked World: A Framework for Protecting Privacy and Promoting 
Innovation in the Global Digital Economy 1 (February 2012).  
7 Protecting Consumer Privacy in an Era of Rapid Change 60 (Federal Trade Commission Report, March 
2012). 
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consumers to make an informed choice about the privacy of their information, including 
whether to transact business with a financial institution.”8  
In order to provide guidance on exactly how to achieve these goals, a number of 
Best Practice protocols have been developed.9 Some of these protocols are mandated by 
law, others are voluntary codes of conduct drafted by lawmakers, and some are complied 
by private groups. We reviewed the recommendations of several of these guides, and 
while there is no universal list of Best Practices, we found six recommendations to be the 
most common. 
1. Titles – use clear titles and headers for the specific provisions. 
2. Layered Information – provide a short-form summary for each provision, 
followed by the more comprehensive information. The long-form should 
appear in smaller font and me even be posted elsewhere, but in such case a 
clear reference or link to it must accompany the short-form summary. 
3. Font – use easily readable type, in a legible size and in a distinct color that 
contrasts distinctly with the background. 
4. Literary Style – use active, not passive, language; short sentences with plain, 
straightforward language. 
5. Examples – when listing categories of personal information that is being 
collected or shared, give concrete examples, rather than ambiguous 
statements, of the type of information in each category. 
6. Names – if the notice refers to partner and affiliated companies, provide their 
names. 
Other Best Practices recommendations are also often made, but they do not directly deal 
with the presentation format. We thus decided to focus on these six common 
recommendations when designing our experimental test of the effectiveness of the formal 
properties of disclosure. 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
8 Federal Trade Commission, Privacy of Consumer Financial Information; Final Rule, 16 CFR Part 313.3 
(65 Fed. Reg. 101 33649, May 24, 2000) (definition of “clear and conspicuous). 
9 See, e.g., California Office of Privacy Protection, Recommended Practices on California Information-
Sharing Disclosures and Privacy Policy Statements 5 (2008); U.S. Department of Commerce, National 
Telecommunications and Information Administration, Short Form Notice Code of Conduct to Promote 
Transparency in Mobile App Practices (July 25, 2013). 
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2.2. Experimental Design 
 
To test the impact of the formal properties of privacy disclosures on respondents’ 
behavior, we needed to set the experiment in a context that met three criteria. First, it had 
to involve questions of sensitive nature, where respondents may be apprehensive about 
sharing personal information, and where we could build on rich prior research in wording 
sensitive questions. Second, it had to allow us to present the subjects with a plausible 
explanation why a corporation would be interested in their personal information. Third, it 
had to be a topic where we could credibly tell respondents that the stakes of the research 
were non-trivial, and as a consequence, that failure to respond truthfully would be 
harmful.  
Ultimately, we elected to frame our survey as consumer research on risky sexual 
behavior. More specifically, we told the respondents that our survey was a study being 
conducted by a for-profit company that is examining risky sexual behavior in order to 
improve matches and reduce sexual harassment in online dating services. This topic 
satisfies the three criteria: sexual practices are a sensitive topic with rich prior research on 
survey design (e.g. Kays, Gathercoat, & Burhow 2012, John, Acquisti, & Loewenstein 
2011); it is reasonable to think that a company developing dating applications would be 
interested in the sexual practices of respondents; and the goal of reducing sexual 
harassment has high stakes.  
The survey started by providing all respondents with the same prompt telling 
them the purpose of the research. Specifically, on the first screen respondents were told: 
 
 “This survey is being conducted by a for-profit company in Chicago 
developing a new commercial application (App) for smartphones that 
provides users novel search tools across all available listings in dating 
sites. The results of this survey will be used to design tools that 
improve relevance of match results and reduce sexual harassment. It is 
important that you answer all questions honestly.”  
 
After reading this prompt, the respondents were asked to click “Next” to start the survey.  
We included this initial prompt for both substantive and practical reasons. The 
substantive reason is to provide a framing for our survey that would accomplish the goals 
we just discussed while also distracting respondents from the fact that we are studying the 
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formal properties of privacy disclosures. The practical reason is to allow us to measure 
the time respondents spent reading the privacy policy disclosures that we presented on 
the following screen because we were able to use when respondents finished the initial 
screen as a start time.  
After the initial prompt, respondents were directed to a screen presenting a 
privacy disclosure. This was the key experimental treatment. Respondents were either 
randomly presented with one of five different privacy disclosures or, as a quasi control 
condition, a blank screen. The privacy disclosures were designed to be realist and were 
based on dozens of actual disclosures used by major businesses and on multiple Best 
Practice guides. The privacy disclosures were also designed to share four attributes. 
First, all of the privacy disclosures began with a prominent title “Your Privacy 
Rights.” This is the primary way users are alerted to the subject matter of privacy policies 
on websites and mobile apps.  
Second, all of the privacy disclosures began by informing the respondents the 
purpose of the disclosure and what it includes, in the following manner:  
 
We value your privacy. In this page, we explain our data privacy practices. We 
explain how we collect, use, disclose, and store the information about you that 
you reveal in the survey. These disclosures of your data and personal information 
may be done without requesting additional consent from you. Additional 
disclosures of your information to government agencies will be made to the extent 
permitted or required by law. Continuing past this page means that you grant us 
permission to engage in these practices, including the permission to share the 
information with others as explained below.10 
 
Third, all of the privacy disclosures covered the same four standard topics: (1) 
“The Information We Collect”; (2) “How We Use the Information”; (3) “Disclosure of 
Data to Third Parties”; (4) “Protection of Personal Information.”  
Fourth, all of the privacy disclosures adopted the same substantive policy for each 
of the four topics. These policies were designed to mirror common privacy practices of 
commercial firms, while still pushing the envelope. For example, respondents were told 
that the firm would share information with commercial health insurance companies, that 
it would link their information to other public and private data sources, and that it would 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
10 The wording was changed slightly for the disclosures that do not use a clear literary style. 
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retain their information indefinitely. Table 1 reports the substantive policies that the 
privacy disclosures adopted.  
 
Table 1: Substantive Policies in the Privacy Disclosures 
The Information We Collect 
• We collect information on your sexual practices based on your responses to questions 
in this survey.  
• We collect personal information that can identify you through this online interaction 
with your computer. 
• We collect and link additional information about you from other public and private 
data sources. 
How We Use the Information  
• We use the information for commercial development of a dating application for 
smartphones. 
• We use the information to develop advertising and marketing tools within the 
application. 
• We use the information to follow up with you on future communications. 
Disclosure of Data to Third Parties 
• We share the information with commercial partners to improve the commercial utility 
of the application. 
• We share the data with advertisers and ad-placement companies that help us design 
the profit opportunities from the mobile application. 
• We share the data with commercial health insurance companies that partner with us in 
developing the data-driven application.  
Protection of Personal Information 
• We retain the information indefinitely. 
• We save your personal information on cloud server with limited access.  
• We encourage our partners to take high security measures in storing your data, but we 
are unable to verify their security practices. 
 
In short, each of the privacy disclosures had the same title, presented the same 
introduction, covered the same topics, and adopted the same substantive policies. This 
allowed us to vary the treatment only in style, not in substance. 
As we previously noted, our preliminary research revealed that there are six Best 
Practices that are most commonly advocated: (1) titles; (2) layered information; (3) clear 
font; (4) easy literary style; (5) examples; and (6) specific names. To test their effect, we 
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developed five versions of a privacy disclosure for our treatment conditions, in addition 
to a sixth, quasi-control, blank treatment:11  
 
1. Best Practice Treatment. All six Best Practices were used.  
2. Organization Treatment. The Best Practice treatment is altered by 
removing the two Best Practices that are related to document organization: 
titles and layered information.  
3. Presentation Treatment. The Best Practice treatment is altered by removing 
the two Best Practices related to ease of read: clear font and easy literary 
style.  
4. Specification Treatment. The Best Practice treatment is altered by removing 
the two Best Practices related to the concreteness of the information: using 
examples and providing specific names for other entities and organizations.  
5. Worst Practice Treatment. None of the six Best Practices were followed.  
6. Blank Treatment. This version simply displayed a blank page on the screen 
that contained a privacy disclosure for the other five treatment groups.  
 
 After being presented with one of these six treatments, the respondents were 
asked to click “Next” at the bottom of the disclosure page to continue the survey. The 
remainder of our survey was designed to test the effects of the privacy disclosures on the 
behavior of the respondents. We will discuss how our survey did so as we discuss our 
results.12 
 
2.3. The Use of Deception  
 
 It is important to acknowledge that our experiment directly deceived the 
respondents. Our decision to use deception, however, is hardly unique. For example, one 
study found that in the years from 1986 to 1997, between 31% and 47% of papers in a top 
social psychology journal used deception in their research design (Hertwig & Ortmann 
2001). The pervasiveness of deception in experimental research is based on the belief that 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
11 Exact wording of the privacy disclosures is presented in Part 1 of the Supplementary Materials.  
12 Exact wording of the survey questions is presented in Part 2 of the Supplementary Materials. 
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it is acceptable when it is essential to the research design and the risks are minimal (see 
generally Morton & Williams 2010, at 500-521).  
Distracting respondents from the fact that we were studying privacy disclosures is 
the only way to ensure that they would react to those disclosures in a normal way. We 
took three steps to minimize the risks to respondents. First, the sensitive questions they 
were asked were based on prior survey research on privacy and thus within accepted 
research standards. Second, all respondents were provided with a debriefing statement 
after the conclusion of the experiment that informed them about the true purpose of our 
research. Third, we followed a data security plan to minimize the risk that any sensitive 
information would be stored or compromised.  
 
 
3. PRIMARY RESULTS 
 
The experiment was administered online to a nationally representative sample 
recruited by Survey Sampling International (SSI). SSI is a leading market research firm 
that primarily conducts surveys for corporate clients. The recruited sample had 1,484 
respondents that were representative of the U.S. adult population based on gender, age, 
ethnicity, and census region.13After the respondents were randomly presented with one of 
the treatments, they were presented with questions designed to measure how the 
disclosure influenced their: (1) comprehension of the disclosure; (2) willingness to share 
personal information; and (3) expectations about their privacy rights.  
 
3.1. Comprehension of the Disclosure 
 
 Respondents’ comprehension of the disclosures was tested in two ways. First, we 
measured the amount of time that respondents spent on the screen displaying the privacy 
disclosures. Second, we asked the respondents questions to measure their comprehension 
of the privacy disclosures.  
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
13 Information on the demographic breakdown of the sample, the number of respondents that received each 
treatment, and the demographic balance across treatment groups is presented in Part 3 of the 
Supplementary Materials.  
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3.1.1. Time on the Disclosure Screen. 
Best Practices intend to make disclosures easier for consumers to understand. But 
how should such ease affect the time spent reading disclosures? People may spend less 
time reading clearer disclosures because they are easier to follow, more time because they 
are less daunting and more accessible, or the same time because they are always clicked 
through as fast as possible. To test which of these effects the formal properties of privacy 
disclosures have, we measured the number of seconds between when respondents clicked 
“Next” on the initial screen to enter the disclosure screen and when respondents clicked 
“Next” to exit the disclosure screen.  
 
Figure 1: Time Spent on the Disclosure Screen  	  
 
 
Figure 1 reports the mean number (and 90% confidence intervals) of seconds that 
the respondents’ in each treatment group spent on the page with the privacy disclosure. 
Figure 1 shows that the mean number of seconds spent on the disclosure screen ranged 
from 19.12 for the Best Practice group to 12.58 for the Blank group. Even though the 
difference in mean seconds between these two groups is the largest discrepancy between 
our six treatments, it is not statistically significant at the 0.1 level (p = 0.43). Since means 
can be influenced by the presence of outliers in the data, Figure 1 also reports the median 
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number of seconds that respondents in each treatment group spent on the disclosure 
screen. The median values are almost indistinguishable: all fall between 4.5 and 6.0 
seconds.  
To put these results in perspective, our privacy disclosures ranged from 499 to 
970 words long, and research suggests that the average college educated adult in the 
United States can read roughly 300 words per minute.14 This suggests that, even ignoring 
the fact that privacy policies like ours unfamiliar terminology (Jensen and Potts 2004), it 
should still take over a minute and a half to read even our shortest disclosure. Not only 
was the median amount of time our respondents spent on the disclosure screen just 5.47 
seconds (just enough to aim and click the “Next” button), but only 2.5% of the 
respondents (36 out of 1,484) spent a minute and a half on the disclosure screen. In other 
words, regardless of the formal properties of the disclosure, nearly all respondents clicked 
through without taking the time to read it.  
Of course, it is possible that the respondents that did take time to read the 
disclosure responded to our survey differently after doing so. In unreported results, we 
analyzed the responses for the respondents that spent at least 30, 60, or 90 seconds on the 
disclosure screen. 15  These “Readers” were more likely to correctly answer the 
comprehension questions discussed in the next section, but these respondents also shared 
roughly the same amount of personal information and largely had the same attitudes as 
the other respondents to our survey.  
 
3.1.2. Correct Answers to Comprehension Questions. 
In addition to measuring the time respondents spent on our privacy disclosure, we 
also directly asked them questions designed to assess their understanding of the 
disclosures. At the end of our survey—after all of the other questions discussed in the 
subsequent sections of this paper—we asked respondents five questions about the 
contents of the privacy policies.  
We specifically asked respondents what our policy is on: (1) the information we 
collect; (2) who we share the data with; (3) how long we retain the data; (4) the security 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
14  See, e.g., <http://www.slate.com/articles/briefing/articles/2000/02/the_1000word_dash.html> (last 
accessed December 21, 2015).  
15 This analysis is presented in Part 5.1 of the Supplementary Materials.  
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measures our partners have to take; and (5) how we responded to data breaches.16 They 
were presented with four possible answers to each question, and one of the options for 
each question was that we did not mention a policy on the topic. We then counted how 
many of these five questions the respondents correctly answered.  
 
Figure 2: Correct Answers to Comprehension Questions 
 
 Figure 2 reports the mean number (and 90% confidence intervals) of questions 
that the respondents’ correctly answered about the contents of our privacy disclosures. 
Most notably, regardless of the format of the disclosure, respondent in all five disclosure 
treatments answered roughly one of the five questions correctly (mean = 0.82). The Best 
Practice group averaged 0.81 questions and the Worst Practice group correctly answered 
0.77 questions—a difference that is far from statistically significant (p = 0.60). Put 
another way, with the exception of the Blank group, the average respondent correctly 
answered fewer questions than would be expected by random chance. The respondents in 
the sixth treatment—the Blank group—answered roughly two of the five questions 
correctly (mean = 1.97), but since the Blank group did not receive a disclosure, the 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
16 These five questions were presented in random order. Although the first four questions were all 
addressed in our privacy disclosures, we the fifth question was not. We included this question, however, 
because it is a commonly covered topic in privacy disclosures, and asking respondents for our policies on it 
provided an additional test of whether our disclosure was actually read. 
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correct answers for them (“We did not mention a policy on the topic”) were different than 
they were for the other treatment groups.  
Among the “Readers” who spent time reading the disclosures, only a very modest 
improvement was observed.17 In that group, about half of the improvement was obtained 
for all treatments, and the majority of that effect was obtained by spending 30 seconds—
hardly enough to read the text. This suggests that the (small) improved comprehension is 
likely due to a selection effect, whereby the longer readers are more sophisticated or 
experienced, rather than to better delivery of the notice. In all, these results suggest that 
for the great majority of people, the formal properties recommend for Best Practice 
disclosures do not improve comprehension of their content.  
 
3.2. Sharing Personal Information 
 
 Disclosures are aimed at changing behavior. In the privacy context, the behavior 
in question is the personal information people share. Thus, the ultimate measure of 
success for Best Practice disclosures is whether they change respondents’ willingness to 
share personal information. We tested this in two ways. First, respondents were asked a 
series of sensitive personal questions about their risky sexual behavior. Second, they were 
asked to provide personal identifying information.  
 
3.2.1. Risky Behaviors Disclosed. 
We asked the respondents a series of questions about their risky sexual behavior 
that were either taken from or based on questions used in other research on this topic (e.g. 
John et al. 2011). We identified ten questions on the subject that could plausibly be 
related to efforts to prevent the spread sexually transmitted diseases (although, 
admittedly, some questions are more relevant to the spread of STDs than others). These 
questions are listed in Table 2. The respondents were asked to answer each of these 
questions either “Yes” or “No”.18 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
17 People who spent at least 90 (60, 30) seconds on the disclosure screen answered correctly 1.25 (1.48, 
1.56) on average, across all treatments. Their score improved to 1.75 (2.33, 1.71) under Best Practice 
treatment. See Part 5.1 of the Supplementary Materials. 
18 The questions were presented in random order and the respondents viewed one question per screen. If 
they attempted to move to the next screen without answering, they were asked, but not required, to provide 
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Table 2: Questions on Risky Sexual Behavior 
1. Have you ever had sex with someone you met the same day? 
2. Have you ever had sex with someone you met the same day without using a condom? 
3. Have you ever cheated on your partner? 
4. Have you ever had anal sex? 
5. Have you ever had sexual thoughts about a member of your same sex? 
6. Have you ever used sex toys? 
7. Have you ever taken nude pictures of yourself or of a sexual partner? 
8. Have you ever been diagnosed with a sexually transmitted disease? 
9. Have you ever lied about how recently you were tests for STDS? 
10. Have you ever neglected to tell a partner about a sexually transmitted disease from 
which you were suffering?  
 
 
 
Figure 3: Risky Behaviors Disclosed 
 
Figure 3 presents the mean number (and 90% confidence intervals) of “Yes” 
responses to these 10 questions.19 Respondents in all six treatment groups answered that 
on average they had engaged between two and three of risky behaviors. The mean 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
a response. Respondents that either answered “No” or advanced without answering were coded the same 
for our analysis.    
19 Part 5.2 of the Supplementary Materials breaks down the tendency to share each of the 10 risky sexual 
behavior questions by treatment groups. Some behaviors are more often shared, but it does not appear that 
there are systematic differences across treatment groups.  
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number of risky behaviors ranges from 2.39 for the Specification group to 2.94 for the 
Worst Practice Group. None of the treatment groups, however, reported a number of 
risky behaviors that was different than the Blank group at the 0.1 level of statistical 
significance. And among the small subset of “Readers:, no measureable differences were 
observed.20 These results suggest that the formal properties recommend for Best Practice 
disclosures do not increase willingness to divulge sensitive information.21  
 
3.2.2. Identifying Information Provided. 
After the risky sexual behavior questions, the respondents were asked a series of 
standard demographic questions.22 After that, they were further asked to provide us with 
five pieces of personal identifying information: (1) the county they took the survey in; (2) 
the zip code where they took the survey; (3) their phone number; (4) their email address; 
and (5) their mailing address. For each question, the respondents had to choose between 
providing the information by filling in a blank answer space or clicking “I prefer not to 
say.” We then recorded the number of times that the respondents provided an answer. In 
general, we could not verify whether the responses were accurate (although we were able 
to conducted some verification of the zip codes provided23).   
Figure 4 reports the mean number (and 90% confidence intervals) of times that 
respondents filled in an answer in the space provided.24 The mean number of questions 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
20 Readers who spent at least 90 seconds disclosed on average a slightly higher number of risky behaviors 
(3.50), but there are too fewer respondents in this group to test which disclosure treatments drive this 
(statistically insignificant) increase. See Part 5.1 of the Supplementary Materials. 
21 Since it is possible that privacy-sensitive subjects would react to the disclosures by terminating their 
participation in the survey, we also examined how many respondents dropped out between being shown the 
survey and the end of our questions on risky sexual behavior. The average drop out rate for the six 
treatments was 3.5%, and there were not any statistically significant differences between the six treatment 
groups. Using best practices, in other words, did not translated into a higher rate of cautionary dropping 
out. 
22 This included asking respondents their age, gender, ethnicity, and the region of the country where they 
lived. The responses to these questions are reported in Part 3 of the Supplementary Materials.  
23 We verified whether the zip code responses matched the zip codes collected by the survey software. 
Although there are a large number of discrepancies, there are not any noticeable trends across treatment 
groups. Further, the great majority of people (84%) and indistinguishably across all treatments provided zip 
codes that were in the vicinity of the location in which they took the survey. See part 5.3 of the 
Supplementary Materials.   
24  Part 5.2 of the Supplementary Materials provides the mean number of “yes” responses to each of the 5 
requests for identifying information by treatment groups. Disaggregating the data reveals that there are 
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that respondents provided an answer for was roughly 2.5 for all six of the treatment 
groups, ranging from 2.40 for the Organization group to 2.58 for the Specification group. 
Once again, none of the treatment groups had average responses that were different than 
the Blank group at the 0.1 level of statistical significance. These results suggest that the 
formal properties recommend for Best Practice disclosures do not increase willingness to 
share identifying information. 
 
Figure 4: Identifying Information Provided 
 
 
 
3.3. Expectations of Privacy Rights 
 
It is possible that even if they are not read or used, that the presence of disclosures 
affects people’s perceptions about the disclosers. For example, in the privacy context, the 
presence of a privacy notice and its format may alter people’s perceptions about their 
legal rights or about how seriously their privacy is being taken (Pan and Zinkhan 2006; 
Proctor et al. 2008). To gain insight on this, we asked the respondents several questions 
on their expectations about their legal rights and reported satisfaction with our survey.  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
differences in the responses by question. For example, roughly 84% of respondents provided a zip code, but 
only 26% of respondents provided a mailing address. Once again, it does not appear that there are 
systematic differences across treatment groups. 
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3.3.1. Expectations About Legal Rights. 
To see if the format of disclosure influences legal expectations, the respondents 
were asked two questions (in random order). First, they were asked if they believed they 
would have a legal claim if we disclosed their data to a third party in a manner consistent 
with our privacy policy. Second, they were asked if they believed they would have a legal 
claim if we disclosed their data to a third party in a manner NOT consistent with our 
privacy policy. For both questions, answers had to be provided on five-point scale 
ranging from “very unlikely” (scored as a 1) to “very likely” (scored as a 5), with 
“neutral” (scored as 3) in between.  
 
Figure 5: Beliefs About Legal Claims 
 
 
 
In Figure 5, Panel A reports the mean response (and 90% confidence intervals) on 
whether respondents believed they had a legal claim if we disclosed their data in a 
manner consistent with our privacy policy. In all treatment groups the response were 
roughly “neutral” (mean = 2.98), without any statistically significant difference across 
disclosure treatments or the Blank group.  
Panel B reports the mean response (and 90% confidence intervals) on whether 
respondents believed they had a legal claim if we disclosed their data in a way NOT 
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consistent with our privacy policy. More respondents thought that it was “likely” that 
they had a legal claim (mean = 3.57). The responses were: Best Practice, 3.61; 
Organization, 3.57; Presentation, 3.50; Specification, 3.52; Worst Practice, 3.49; and 
Blank, 3.73. Unlike our prior tests, for this questions three of the treatment groups had 
average responses that were different than the Blank group at a statistically significant 
level: the Presentation group (p = 0.03), the Specification group (p = 0.06), and the Worst 
Practice group (p = 0.04). That said, the differences between the Best Practice group and 
these groups were not statistically significant. Although this is weak evidence that the 
presence of privacy disclosures may lull respondents to think that disclosers are acting 
legally and that no legal violation is being committed, it does not support the more 
nuanced notion that a Best Practice disclosure would create different expectations than a 
poorly presented disclosure.  
 
3.3.2. Reported Satisfaction. 
 
Finally, even if Best Practices do not change consumers’ comprehension or 
decisions to share personal information, clearer disclosures may increase consumer 
satisfaction. We tested this by asking respondents two questions (in random order): 
“[h]ow satisfied are you that we take your privacy seriously?” and “[h]ow satisfied are 
you with your experience taking this survey?” For both questions, answers had to be 
provided on five-point scale ranging from “very dissatisfied” (scored as a 1) to “very 
satisfied” (scored as a 5). 
In Figure 6, Panel A reports the mean level of satisfaction (and 90% confidence 
intervals) that respondents had about whether we were taking their privacy seriously. 
Overall, the respondents were roughly “satisfied” that we were taking their privacy 
seriously (mean = 4.09). The responses were near identical across all six of the treatment 
groups, and none of the treatments had an average response that was different from the 
Blank group at a statistically significant level. This is interesting, in part, because our 
privacy disclosures announced a number of aggressively unpleasant policies that should 
diminish people’s satisfaction. We already established that the content was largely 
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ignored, and we now see that the format did not affect the overall impression people 
gleaned from their exposure to the disclosure page.  
 
Figure 6: Reported Satisfaction 
 
 
 
Panel B reports the mean level of satisfaction (and 90% confidence intervals) that 
respondents had taking our survey. Like with the prior question on privacy, the 
respondents were roughly “satisfied” with their experience taking our survey (mean = 
3.95), the responses were near identical across all six of the treatment groups, and none of 
the treatments had an average response that was different from the Blank group at a 
statistically significant level. In other words, providing a privacy disclosure—no matter 
the formatting—did not change the respondents’ attitude about a survey asking highly 
intimate questions about their sexual history.  
 
4. SIMPLIFICATION BY A “WARNING LABEL” 
 
4.1. Overview 
 
 Our results thus far did not identify any statistically significant differences 
between the treatments groups’ comprehension and behavior (and only very weak and 
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unintended effects on legal expectations). In short, despite the intrusive information they 
were asked to share and the nasty privacy practices we pretended to have, the respondents 
that received the Best Practice disclosure and those that received the Worst Practice 
disclosure responded indistinguishably.  
 Perhaps this suggests that although Best Practices are widely supported, they may 
not go far enough. They still require more time to review and contemplate than most 
people are willing to spend. More radical forms of simplification may therefore be 
deemed necessary, and several templates along these lines have been offered. They all 
share the principle that disclosures should provide very few facts in a very short format, 
and that they should focus on policies that are easiest for people to understand, process, 
and compare. Nutrition data labels are viewed as model for these kinds of designs. One 
prominent version of this approach is the warning label proposal in Ayres and Schwartz 
(2014)—a disclosure of legal terms containing only a handful of facts that are most 
surprising and disadvantageous to consumers.  
Despite the fact that these warning label style disclosures have some intuitive 
appeal, we are unaware of research that has tested whether they lead consumers to behave 
differently than a more conventional Best Practice disclosure would. We therefore added 
a treatment to our survey that would allow us to test the impact of warning label 
disclosures. Since Ayres and Schwartz (2014) already focused in their proposal on 
privacy disclosures, we used their approach as our model.  
 
4.2. Research Design 
A short warning label needs to include only the utmost important items, and those 
might vary across firms. Accordingly, Ayres and Schwatz (2014) propose that firms 
should conduct research to learn which aspects of their policy are least expected. In that 
spirit, we administered a short preliminary survey to our colleagues and students, asking 
them to examine the twelve terms in the privacy policy we developed for our experiment 
(as listed in Table 1). They were asked to rank the terms are on a scale from “strong 
unexpected” to “strongly expected,” based on what they would expect for a survey on 
sexual practices being conducted by a corporation.25 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
25 Information on the preliminary survey is presented in Part 6 of the Supplementary Materials.  
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Figure 7: “Warning Label” Style Disclosure 
 
 
 
 Based on the responses to this preliminary survey, we created a warning label 
containing only the five items that were ranked as the most unexpected. Figure 7 presents 
the warning label disclosure we designed, which is almost identical to the one proposed 
by Ayres and Schwartz (2014). We then ran our experiment—exactly as Part 2.3 
described—but, instead of a standard privacy disclosure, presented some respondents 
with a Warning Label disclosure.   
 
4.3. Results  
 Since the results in Part 3 were nearly identical for all five our of privacy 
disclosures, the figures in this section simply report the comparison of the results for the 
“Best Practices” treatment and the new “Warning Label” treatment.  
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Figure 8: Comprehension of the Warning Label 
 
 
 
 
Figure 8 reports the results for the two tests we designed to measure respondents’ 
Comprehension of the Disclosures. Panel A shows that the amount of time spent on the 
disclosure screen was nearly identical for the respondents that received the Best Practice 
treatment (mean = 19.12 seconds; median 5.61 seconds) and the respondents that 
received Warning Label treatment (mean = 18.56 seconds; median = 6.78 seconds). Panel 
B, however, shows that there was a difference in the number of correct answers to the 
comprehension questions. While respondents that received the Best Practice disclosure 
averaged 0.81 correctly answered questions, the respondents that received the Warning 
Label treatment averaged 1.53 correctly answered questions. This difference is highly 
statistically significant (p < 0.001).  
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Figure 9: Willingness to Share Personal Information 	  
 
 
 
Figure 9 reports the results of our two tests that measured respondents’ 
willingness to share personal information. Panel A shows that the number of risky 
behaviors that respondents disclosed is comparable for both groups. On average, the Best 
Practice group reported having engaged in 2.70 risky behaviors and the Warning Label 
group reported having engaged in 2.51 risky behaviors. This difference is not statistically 
significant. Similarly, Panel B shows that the number of answers the respondents in both 
groups provided to the questions asking for identifying information. On average, the Best 
Practice group provided answers to 2.44 questions asking for identifying information and 
the Warning Label group provided answers to 2.72. This result is statistically significant 
at the 0.1 level (p = 0.07). In other words, this evidence suggests that respondents were 
slightly more likely to provide identifying information when we provided them with a 
warning label that only listed the most unexpected ways we would use their data.  
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Figure 10: Attitudes About Our Survey 
 
 
 
Figure 10 reports respondents’ answers regarding attitudes about our survey. 
Panel A and B reports respondents’ legal expectations in case we shared their data with a 
third party, and Panel C and D reports respondents’ satisfaction. For all four questions, 
the differences among the Best Practice group and Warning Label group were minor and 
far from statistically significant.  
 
4.4. Discussion 
The Warning Label group did show some improved understanding of the terms. 
That said, the respondents were far from fluent: only 1.53 answers correct, out of five 
(compared to an average of less than 1 for other treatments). This is likely attributable to 
the ease of reading a five-item warning box relative to even a well-designed disclosure 
form. But this small improvement did not translate into any detectable difference in 
behavior. Only very minor differences were recorded in the willingness to share 
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information despite the fact that the warning label cautioned people about the problematic 
uses of the information.26  
These findings suggest different lessons compared to prior literature that tested 
nutrition box modules of privacy disclosures (Kelley et al. 2010). Like prior work, we 
also see some improved understanding (although the effect is more modest). But unlike 
prior work, we see no change in the primary conduct. When disclosures are presented in 
the context of another task, their presentation format is found to be irrelevant. 
It is possible that the disappointing effect of the warning label merely reflects 
current numbness among subjects, unmotivated to use privacy notices of any kind. It 
might be that in an environment where warning labels become the norm, people would 
learn to utilize them. Experimental methodology necessarily falls short of testing such 
market-wide effect, but some observational data casts doubt about this conjecture 
(Agarwal et. Al 2014). 
 
5. CONCLUSION 
 
Simplification of disclosures is one of the most widely pursued regulatory 
techniques of our time. The simplification paradigm makes much sense in theory, but 
proof of its success has so far been elusive. Our experimental results contribute to a 
skeptical view on the merits of simplification. Of course, there are limitations to our 
approach. For example, it may be the case that people that agree to take an online survey 
responded to privacy disclosures differently than the general public. Additionally, we 
only tested two simplification formats—a Best Practice presentation and a warning 
label—when there are surely more formats that could be tried. But with those caveats in 
mind, we found that that the simplification of disclosures did not change people’s 
understanding of them or their ensuing behavior in any meaningful direction. 
Upon further reflection, these results may not be so surprising. As explained 
elsewhere, “simplicity’s failure grows out of mandated disclosure’s concern with 
complex and unfamiliar issues. Complexity can rarely be described simply to people 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
26 We also detected a modest and statistically significant increase in the subjects’ drop out rate under the 
warning label treatment. For the Best Practice treatment, 3.4% of the respondents dropped out of the survey 
before the end of the questions on risky sexual behavior, and this rate increased to 6.3% under the warning 
label treatment.  
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unfamiliar with it” (Ben-Shahar and Schneider 2014, p. 135). Firms’ privacy practices are 
only one complex topic in a host of issues which disclosures address. If simplification 
fails in this context, is there a reason to expect it to perform better in other areas?   
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1. PRIVACY DISCLOSURES 
 
1.1. Best Practice Disclosure 
 
Your Privacy Rights 
 
We value your privacy. In this page, we explain our data privacy practices. We explain 
how we collect, use, disclose, and store the information about you that you reveal in the 
survey.  
 
These disclosures of your data and personal information may be done without requesting 
additional consent from you. Additional disclosures of your information to government 
agencies will be made to the extent permitted or required by law. 
 
Continuing past this page means that you grant us permission to engage in these 
practices, including the permission to share the information with others as explained 
below. 
 
The Information We Collect 
 
• We collect information on your sexual practices based on your responses to questions 
in this survey.  
For Example, in the survey, you will be asked about your behavior in various 
intimate sexual situations. You do not have to provide responses, but if you do we 
collect your answers. 
 
• We collect personal information that can identify you through this online interaction 
with your computer. 
For Example, we collect information about your IP address, geographical 
location, zip code, the type of computer you use in this survey and its operating 
system, your Internet service provider, and clickstream data.  
 
• We collect and link additional information about you from other public and private 
data sources. 
For Example, we collect information about you from social media sites and 
insurance databases. 
 
How We Use the Information  
 
• We use the information for commercial development of a dating application for 
smartphones. 
For Example, we use the information to create statistical tools that predict sexual 
behavior risks that confront people who give answers like yours.    
 
• We use the information to develop advertising and marketing tools within the 
application. 
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For Example, we develop a database that matches people with answers like the 
ones you provide with products that they may wish to purchase. 
 
• We use the information to follow up with you on future communications. 
For Example, we might send you offers to access our new application and ads 
tailored to the preferences you reveal. We will also communicate with you if there 
are changes to this Privacy Policy. 
 
 
Disclosure of Data to Third Parties 
 
• We share the information with commercial partners to improve the commercial utility 
of the application. 
For Example, we share the information with dating sites that process and analyze 
your responses and match them with existing databases. 
 
• We share the data with advertisers and ad-placement companies that help us design 
the profit opportunities from the mobile application. 
For Example, we disclose the information to Ad-Med Solutions, Inc., a 
commercial company affiliated with our business, that is offering personalized 
medical advertisements. Ad-Med Solutions, Inc., may further share the 
information with its affiliates and partners or sell it to others.  
 
• We share the data with commercial health insurance companies that partner with us in 
developing the data-driven application.  
For Example, we disclose the information to MHM Insurance (Midwestern Health 
Mutual Insurance), a health insurance company specializing in personalized 
health policies. MHM may share the information with its affiliates and partners, 
beyond our control, and use it for the development of its health insurance 
business. 
 
Protection of Personal Information 
 
• We retain the information indefinitely. 
For Example, we may keep files containing your personal information even if we 
merge with another business. 
 
• We save your personal information on cloud server with limited access.  
For Example, we encrypt any files containing personal information when we 
transmit them to cloud-based data files. 
 
• We encourage our partners to take high security measures in storing your data, but we 
are unable to verify their security practices. 
For Example, we request that any of our partners receiving your personal 
information protect it by passwords and encryption, and ask the same if they pass 
the information onward. 
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1.2. Organization Disclosure 
 
[Note: This disclosure starts with the Best Practice Disclosure, but deletes all the 
formatting. It then adds two extra paragraphs (on children’s rights and the citizens of 
Vermont), and also adds a few redundant sentences to start each paragraph.] 
 
Your Privacy Rights 
	  
We value your privacy. In this page, we explain our data privacy practices. We explain 
how we collect, use, disclose, and store the information about you that you reveal in the 
survey. These disclosures of your data and personal information may be done without 
requesting additional consent from you. Additional disclosures of your information to 
government agencies will be made to the extent permitted or required by law. Continuing 
past this page means that you grant us permission to engage in these practices, including 
the permission to share the information with others as explained below. 
 
This policy covers the survey as well as any interactions you may have with us. When 
you review this survey, please keep in mind that it is intended for a U.S. audience and the 
information may be processed or transferred in the United States. Our survey is not 
intended for children under 13. We do not knowingly collect personal information from 
children under 13. If you have any relation with the survey group and any of its affiliates, 
we may collect information about you. If you have any questions after reviewing this 
policy, please address them according to the directions provided below.  
 
In this survey we collect information on your sexual practices based on your responses to 
questions in this survey. You do not have to provide responses, but any response you 
provide is collected and stored. This includes information about sexual behavior in the 
present and in the past, how your behavior is affected by risks including risks of sexually 
transmitted diseases, and other information related to sexual conduct that you provide us.  
 
We collect information on your sexual practices based on your responses to questions in 
this survey. For Example, in the survey, you will be asked about your behavior in various 
intimate sexual situations. You do not have to provide responses, but if you do we collect 
your answers. We collect personal information that can identify you through this online 
interaction with your computer. For Example, we collect information about your IP 
address, geographical location, zip code, the type of computer you use in this survey and 
its operating system, your Internet service provider, and clickstream data. We collect and 
link additional information about you from other public and private data sources. For 
Example, we collect information about you from social media sites and insurance 
databases. 
 
We use the information for market research in the development of a new commercial 
dating application for smartphones, including the development of new products and 
services embedded in this application, the improvement of existing products and services, 
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the performance of data analytics, and other internal functions. We use the information 
for commercial development of a dating application for smartphones. For Example, we 
use the information to create statistical tools that predict sexual behavior risks that 
confront people who give answers like yours. We use the information to develop 
advertising and marketing tools within the application. For Example, we develop a 
database that matches people with answers like the ones you provide with products that 
they may wish to purchase. We use the information to follow up with you on future 
communications. For Example, we might send you offers to access our new application 
and ads tailored to the preferences you reveal. We will also communicate with you if 
there are changes to this Privacy Policy. 
 
We share the information we collect from and about you with our affiliates and other 
third parties. We share some of the information with commercial partners to improve the 
accuracy and commercial utility of the application, to help us perform some of the 
analytics of this study, and to collaborate with partners that develop related products, 
services, advertisements, and technical capabilities. We share the information with 
commercial partners to improve the commercial utility of the application. For Example, 
we share the information with dating sites that process and analyze your responses and 
match them with existing databases. We share the data with advertisers and ad-placement 
companies that help us design the profit opportunities from the mobile application. For 
Example, we disclose the information to Ad-Med Solutions, Inc., a commercial company 
affiliated with our business, that is offering personalized medical advertisements. Ad-
Med Solutions, Inc., may further share the information with its affiliates and partners or 
sell it to others. We share the data with commercial health insurance companies that 
partner with us in developing the data-driven application. For Example, we disclose the 
information to MHM Insurance (Midwestern Health Mutual Insurance), a health 
insurance company specializing in personalized health policies. MHM may share the 
information with its affiliates and partners, beyond our control, and use it for the 
development of its health insurance business. 
 
Residents of Vermont: We will not share personally identifiable information unless 
authorized by you. This does not limit us from sharing certain information about your 
response to the survey as permitted by law.  
 
We want you to feel confident about using this website to respond to the survey, and we 
are committed to protecting the information we collect. While no online platform can 
guarantee security, we have implemented appropriate administrative, technical, and 
physical security procedures to help protect the personal information you provide to us. 
We retain the information indefinitely. For Example, we may keep files containing your 
personal information even if we merge with another business. We save your personal 
information on cloud server with limited access. For Example, we encrypt any files 
containing personal information when we transmit them to cloud-based data files. We 
encourage our partners to take high security measures in storing your data, but we are 
unable to verify their security practices. For Example, we request that any of our partners 
receiving your personal information protect it by passwords and encryption, and ask the 
same if they pass the information onward. 
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1.3. Presentation Disclosure 
 
[Note: This disclosure starts with the Best Practice Disclosure, and then changes the font 
to gray italics & turned into passive voice]. 
 
Your Privacy Rights 
 
Your privacy is valued by us. In this page, our data privacy practices are explained. It is 
explained how the information revealed by you is in the survey collected, used, disclosed, 
transferred, and stored by us.  
 
Without requesting additional consent from you, these disclosures of your data and 
personal information may be done. To the extent permitted or required by law, additional 
disclosures of your information to government agencies will be made. 
 
Continuing past this page means that permission to engage in these practices is granted 
to us, including the permission to share the information with others, as explained below. 
 
The Information We Collect 
 
• Information on your sexual practices will be collected by us based on your responses 
to questions in this survey.  
For Example, in the survey, you will be asked about your behavior in various 
intimate sexual situations. Responses do not have to be provided by you, but they 
are they will be collected by us. 
 
• Personal information that can identify you will be collected by us through this online 
interaction with your computer.  
For Example, information is collected about your IP address, geographical 
location, zip code, the type of computer being uses in this survey and its operating 
system, your Internet service provider, and clickstream data.  
 
• Additional information about you from other public and private data sources will be 
collected and linked by us.  
For Example, information about you from social media sites and insurance 
databases may be collected. 
 
How We Use the Information  
 
• Your information will be used by us for a dating application for smartphones being 
commercial developed. 
For Example, the information is used for statistical tools to be developed, through 
which sexual behavior risks confronted by people who give answers like yours are 
predicted. 
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• Your information will be used by us for advertising and marketing tools that are 
being developed within the application. 
For Example, a database that matches people with answers like the ones provided 
by you with products that they may wish to purchase is being developed. 
 
• Your information will be used in future communications that would be followed up 
with by us.  
For Example, offers to access to our new application as well as ads tailored to the 
preferences revealed by you may be sent to you. Also, changes to this Privacy 
Policy will be communicated. 
 
Disclosure of Data to Third Parties 
 
• So that the commercial utility of the application be improved, the information 
collected will be shared by us with commercial partners.  
For Example, information will be shared with dating sites in which your 
responses are processed and analyzed, and matched with existing databases. 
 
• So as to help us design the profit opportunities from the mobile application, the 
information will be shared by us with advertisers and ad-placement companies.  
For example, information will be disclosed to Ad-Med Solutions, Inc., a 
commercial company affiliated with our study that is developing personalized 
medical advertisements. The information may further be shared by Ad-Med 
Solutions, Inc., with its affiliates and partners or sold to others.  
 
• So that the data-driven application can be developed, the information will be shared 
by us with health insurance companies with whom we are partnered. 
For Example, information will be disclosed to MHM Insurance (Midwestern 
Health Mutual Insurance), a health insurance company specializing in 
personalized health policies. The information may be further shared by MHM 
with its affiliates and partners, beyond our control, and may be used by it for the 
development of its health insurance business. 
 
Protection of Personal Information 
 
• Your personal information will be retained by us indefinitely.  
For Example, files in which your personal information is contained will be kept 
even if we are merged with another business. 
 
• Your personal information will be saved by us on cloud server accessed in limited 
fashion. 
For Example, any files in which personal information is contained will be 
encrypted when transmitted to cloud-based data files. 
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• Our research partners will be encouraged to take high security measures in the way 
your data is being stored by them, but their security practices cannot be verified by 
us. 
For Example, any of our partners with whom your personal information will be 
shared will be requested to protect it by password and encryption, and asked to 
do the same the same if the information is passed onward. 
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1.4. Specification Disclosure 
 
[Note: This disclosure uses the bullet points from the Best Practice Disclosure, but 
deletes all the examples and replaces them with abstract repetitive text]. 
 
Your Privacy Rights 
 
We value your privacy. In this page, we explain our data privacy practices. We explain 
how we collect, use, disclose, and store the information about you that you reveal in the 
survey.  
 
These disclosures of your data and personal information may be done without requesting 
additional consent from you. Additional disclosures of your information to government 
agencies will be made to the extent permitted or required by law. 
 
Continuing past this page means that you grant us permission to engage in these 
practices, including the permission to share the information with others as explained 
below. 
 
The Information We Collect 
 
• We collect information on your sexual practices based on your responses to questions 
in this survey. You do not have to provide responses, but if you do we collect your 
answers. 
 
• We collect personal information that can identify through this online interaction with 
your computer. This personal information is intended to customize in a statistical and 
automated manner your profile. 
 
• We collect additional information about you from other public and private data 
sources. We collect about you from third-party databases. 
 
How We Use the Information  
 
• We use the information for commercial development of a dating application for 
smartphones. The results of this survey will be used to design tools that improve 
relevance of match results and reduce sexual harassment. 
 
• We use the information to develop advertising and marketing tools within the 
application. The information will be used to make changes to our applications. 
 
• We use the information to follow up with you on future communications. We will 
also contact you if there are issues relating to the study or to this survey that require 
further clarification or communication.  
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Disclosure of Data to Third Parties 
 
• We share the information with commercial partners to improve the commercial utility 
of the application. We share some of the information with affiliates partners to help 
us perform some of the goals of this application, and to collaborate with other 
commercial entities that specialize in this field. 
 
• We share the data with advertisers and ad-placement companies that help us design 
the profit opportunities from the mobile application. This includes companies and 
affiliates that offer commercial services, products, or programs in the area of 
personalized dating services, and affiliates and partners of such companies. 
 
• We also share the data with commercial health insurance companies that partner with 
us in developing the data-driven application. Sharing data with these companies helps 
us to further develop the utility of our application. 
 
 
Protection of Personal Information 
 
• We retain the information indefinitely. Any data we collect about you may not be 
deleted and may be used in future business.   
 
• We save your personal information on cloud server with limited access. We protect 
access to the information through our internal data protection and security.  	  
• We encourage our partners to take high security measures in storing your data, but we 
are unable to verify their security practices. We encourage our partners to require 
their own affiliates to maintain high security standards.  
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1.5. Worst Practice Disclosure 
 
[Note: This disclosure starts with the Organization Disclosure and inserts passive voice 
for all the topic sentences. Then the “bullet” points from the Presentation Disclosure are 
used, and the repetitive sentences from the Specification Disclosure are used instead of 
examples.] 
 
 
Your Privacy Rights 
	  
Your privacy is valued by us. In this page, our data privacy practices are explained. It is 
explained how the information revealed by you is in the survey collected, used, disclosed, 
transferred, and stored by us. Without requesting additional consent from you, these 
disclosures of your data and personal information may be done. To the extent permitted 
or required by law, additional disclosures of your information to government agencies 
will be made. Continuing past this page means that permission to engage in these 
practices is granted to us, including the permission to share the information with others, 
as explained below. 
 
This policy covers the survey as well as any interactions you may have with us. When this 
survey is being reviewed by you, please keep in mind that it is intended for a U.S. 
audience and the information may be processed or transferred in the United States. Our 
survey is not intended for children under 13. Personal information from children under 
13 is not knowingly collected by us. If you have any relation with the survey group and 
any of its affiliates, we may collect information about you. If you have any questions after 
reviewing this policy, have them addressed according to the directions provided below.  
	  
Information on your sexual practices will be collected by us based on your responses to 
questions in this survey. Responses do not have to be provided, but any response that is 
provided is collected and stored. This includes information about sexual behavior in the 
present and in the past, how your behavior is affected by risks including risks of sexually 
transmitted diseases, and other information related to sexual conduct that you provide us. 
Information on your sexual practices will be collected by us based on your responses to 
questions in this survey. You do not have to provide responses, but if you do we collect 
your answers. Personal information that can identify you will be collected by us through 
this online interaction with your computer. This personal information is intended to 
customize in a statistical and automated manner your profile. Additional information 
about you from other public and private data sources will be collected and linked by us. 
We collect about you from third-party databases. 
 
Your information will be used by us for market research in the development of a new 
commercial dating application for smartphones, including the development of new 
products and services embedded in this application, the improvement of existing products 
and services, the performance of data analytics, and other internal functions. Your 
information will be used by us for a dating application for smartphones being 
commercial developed. The results of this survey will be used to design tools that improve 
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relevance of match results and reduce sexual harassment. Your information will be used 
by us for advertising and marketing tools that are being developed within the application. 
The information will be used to make changes to our applications. Your information will 
be used in future communications that would be followed up with by us. We will also 
contact you if there are issues relating to the study or to this survey that require further 
clarification or communication.  
 
To improve the accuracy of our findings the information will be shared by us with 
affiliates and other third parties. Some of the information is shared with commercial 
partners so that the accuracy of our findings be improved, that the analytics of this study 
be performed, and collaboration with partners that develop related products, services, 
advertisements, and technical capabilities be pursued. So that the commercial utility of 
the application be improved, the information collected will be shared by us with 
commercial partners. We share some of the information with affiliates partners to help us 
perform some of the goals of this application, and to collaborate with other commercial 
entities that specialize in this field. So as to help us design the profit opportunities from 
the mobile application, the information will be shared by us with advertisers and ad-
placement companies. This includes companies and affiliates that offer commercial 
services, products, or programs in the area of personalized dating services, and affiliates 
and partners of such companies. So that the data-driven application can be developed, 
the information will be shared by us with health insurance companies with whom we are 
partnered. This includes companies and affiliates that offer commercial services, 
products, or programs in the area of personalized dating services, and affiliates and 
partners of such companies. 
 
Residents of Vermont: Unless authorized by you, personally identifiable information will 
not be shared by us. This does not limit us from sharing certain information about your 
response to the survey as permitted by law.  
 
We want you to feel confident about using this website to respond to the survey and we 
are committed to protecting the information being collected by us. While no online 
platform can guarantee security, appropriate administrative, technical, and physical 
security procedures have been implemented by us to help protect the personal 
information that is being provided to us. Your personal information will be retained by us 
indefinitely. Any data we collect about you may not be deleted and may be used in future 
business. Your personal information will be saved by us on cloud server accessed in 
limited fashion. We protect access to the information through our internal data 
protection and security. Our research partners will be encouraged to take high security 
measures in the way your data is being stored by them, but their security practices cannot 
be verified by us. We encourage our partners to require their own affiliates to maintain 
high security standards. 
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2. SURVEY QUESTIONS 
 
2.1. Risky Behavior Questions 
 
1. Have you ever had sex with someone the same day you met them? 
A. Yes 
B. No 
 
2. Have you ever had sex with someone you met the same day without a condom?  
A. Yes 
B. No 
 
3. Have you ever cheated on your partner? 
A. Yes 
B. No 
 
4. Have you ever had anal sex? 
A. Yes 
B. No 
 
5. Have you ever had sexual thoughts about a member of your same sex? 
A. Yes 
B. No 
 
6. Have you ever used sex toys? 
A. Yes 
B. No 
 
7. Have you ever taken nude pictures of yourself or of a sexual partner? 
A. Yes 
B. No 
 
8. Have you ever been diagnosed with a sexually transmitted disease? 
A. Yes 
B. No 
 
9. Have you ever lied about how recently you were tested for STDs? 
A. Yes 
B. No 
 
10. Have you ever neglected to tell a partner about a sexually transmitted disease from 
which you were suffering?  
 
A. Yes 
B. No 
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2.2. Personal Information Questions 
 
1. In which county did you take this survey? 
A. _____________ 
B. Prefer not to say. 
 
2. What is the zip code where you took this survey? 
A. _____________ 
B. Prefer not to say. 
 
3. What is your phone number?  
A. _____________ 
B. Prefer not to say. 
 
4. What is your email address? 
A. _____________ 
B. Prefer not to say. 
 
5. What is your mailing address?  
A. _____________ 
B. Prefer not to say. 
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2.3. Comprehension Questions 
 
1. What is our policy on the information we collect? 
a) We retain the right to collect information about you from facebook 
b) We only collect your answers to this survey 
c) We collect, among other things, information based on our online interaction with 
your computer (* correct answer) 
d) We did not mention what types of data we collect 
 
2. What is our policy on whom we share your data with?  
a) We share data with commercial health insurance companies (* correct answer) 
b) We do not share your data with anyone outside our company 
c) We share your data with any interested third parties 
d) We did not mention a policy on how long we will retain your data 
 
3. What is our policy on how long we retain your data?  
a) We will immediately delete your data after analyzing the results of this survey 
b) We will delete your data after one year 
c) We will retain your data indefinitely (* correct answer) 
d) We did not mention a policy on how long we will retain your data 
 
4. What is our policy on the security measures our partners have to take? 
a) We do not discuss security measures with anyone we share your data with  
b) We encourage anyone we share your data with to take high security measures (* 
correct answer) 
c) We verify that anyone we share your data with take high security measures 
d) We did not mention any policy on data security  	  
5. What is our policy on how to respond to data breaches? 
a) We will immediately contact you about any data breaches 
b) We will take aggressive legal action against those responsible for data breaches 
c) We will work with the government to investigate any data breaches d) We did not mention a policy on how we respond to data breaches (* correct 
answer)	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2.4. Expectations of Privacy Questions 
 
1. If we comply with all of the policies contained in our statement on “Your Privacy 
Rights”, how likely do you think it is that you would have a legal claim against us 
if we share your data with a third party? 
a) Extremely likely 
b) Likely 
c) Neutral 
d) Unlikely 
e) Extremely unlikely 
 
2. If we DO NOT comply with all of the policies contained in our statement on 
“Your Privacy Rights”, how likely do you think it is that you would have a legal 
claim against us if we share your data with a third party? 
a) Extremely likely 
b) Likely 
c) Neutral 
d) Unlikely 
e) Extremely unlikely 
 
3. How satisfied are you that we take your privacy seriously? 
a) Very satisfied 
b) Somewhat satisfied 
c) Neither satisfied or dissatisfied 
d) Somewhat dissatisfied 
e) Very dissatisfied 
 
4. How satisfied are you with your experience taking this survey?  
a) Very satisfied 
b) Somewhat satisfied 
c) Neither satisfied or dissatisfied 
d) Somewhat dissatisfied 
e) Very dissatisfied 
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3. INFORMATION ABOUT OUR SAMPLE 
 
A sample of 1,484 respondents was recruited by Survey Sampling International (SSI). 
SSI is a leading market research firm that primarily conducts surveys for corporate 
clients. First, we provide the demographic breakdown of our sample compared the adult 
population of the United States. Second, we provide the number of respondents that 
received each treatment. Third, we present the results of testing we conducted to make 
sure that the respondents in each of the treatment groups were balanced.   
 
 
3.1. Demographic Characteristics of Our Sample 
 
Demographic Characteristics of Our Sample 
 #  
in Sample 
%  
of Sample  
% of U.S. 
Population 
Gender    
Male 695 47% 48% 
Female 789 53% 52% 
Age    
18-24 174 12% 13% 
25-34 270 19% 18% 
35-44 278 19% 18% 
45-54 275 19% 19% 
55-64 235 16% 16% 
65+ 251 17% 17% 
Race/Ethnicity    
White 1,020 69% 69% 
Hispanic 191 13% 14% 
Black 180 12% 11% 
Asian 60 4% 4% 
Other 32 2% 2% 
Region    
Northeast 273 18% 18% 
Midwest 322 22% 22% 
South 544 37% 37% 
West 345 23% 23% 
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3.2 Number of Respondents by Treatment Group 
 
 
Number of Respondents by Treatment 
Treatment Respondents 
1. Best Practice 203 
2. Organization 220 
3. Presentation 211 
4. Specification 199 
5. Worst Practice 213 
6. Blank 229 
7. Warning Label 209 
Complete Sample 1,484 
 
 
 
3.3. Balance Testing 
 
Before analyzing the results of our survey, we tested to make sure that the groups that 
received each of our six treatments were similar. To do so, we used the balance test from 
Hansen & Bowers (2008) to evaluate whether there was any evidence of imbalance 
among demographic variables reported in the Table in Part 3.1 of the Supplementary 
Materials.1  
 
Using this test, the overall χ2 statistic and the associated overall p-values for each group 
are: Best Practice, 11.3 (p = 0.33); Organization, 10.2 (p = 0.42); Presentation, 5.91 (p = 
0.82); Specification, 14.6 (p = 0.15); Worst Practice, 16.2 (p = 0.09); Blank, 11.3 (p = 
0.34), and Warning Label, 8.1 (p = 0.62). There suggests that our seven treatment groups 
are largely balanced, although we cannot reject the possibility of some imbalance for our 
Worst Practice Treatment group.  
 
 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Hansen, Ben B. and Jake Bowers. 2008. Covariate Balance in Simple, Stratified and 
Clustered Comparative Studies. Statistical Science 23(2): 219-236.  
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4. COMPLETE RESULTS 
 
 
4.1. Time on the Disclosure  	  
 
 
 
 
Treatment Mean Median 90% Confidence Interval 
1. Best Practice 19.12 5.61 5.07 33.16 
2. Organization 15.25 4.67 10.83 19.68 
3. Presentation 16.23 5.99 12.51 20.03 
4. Specification 13.78 5.51 10.90 16.66 
5. Worst Practice 14.62 4.68 10.85 18.39 
6. Blank 12.58 5.50 5.85 19.32 
7. Warning Label 18.56 6.78 9.69 27.44 
Complete Sample 15.69 5.47 13.18 18.21 
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4.2. Number of Correct Answers 
 	  
 
 
 
Treatment Mean Median 90% Confidence Interval 
1. Best Practice 0.81 1.00 0.71 0.91 
2. Organization 0.91 1.00 0.82 0.99 
3. Presentation 0.80 1.00 0.71 0.89 
4. Specification 0.84 1.00 0.73 0.94 
5. Worst Practice 0.77 1.00 0.68 0.85 
6. Blank 1.97 1.00 1.75 2.19 
7. Warning Label 1.53 1.00 1.39 1.68 
Complete Sample 1.100 1.00 1.05 1.15 
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4.3. Risky Behaviors 
 	  
 
 
 
 
Treatment Mean Median 90% Confidence Interval 
1. Best Practice 2.70 2.00 2.40 3.00 
2. Organization 2.80 2.00 2.53 3.08 
3. Presentation 2.55 2.00 2.28 2.83 
4. Specification 2.39 2.00 2.12 2.66 
5. Worst Practice 2.94 3.00 2.66 3.21 
6. Blank 2.63 2.00 2.36 2.89 
7. Warning Label 2.51 2.00 2.23 2.79 
Complete Sample 2.65 2.00 2.55 2.76 
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4.4. Identifying Information Provided 
 
 
 
 
 
 
Treatment Mean Median 90% Confidence Interval 
1. Best Practice 2.44 2.00 2.25 2.63 
2. Organization 2.40 2.00 2.56 2.55 
3. Presentation 2.47 2.00 2.29 2.65 
4. Specification 2.58 2.00 2.40 2.77 
5. Worst Practice 2.43 2.00 2.25 2.62 
6. Blank 2.48 2.00 2.32 2.65 
7. Warning Label 2.72 2.00 2.55 2.89 
Complete Sample 2.50 2.00 2.44 2.57 
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4.5. Certainty About Legal Claims 
 	  
 
 
 
 
Treatment Mean Median 90% Confidence Interval 
Panel A – Legal Claim if We Comply 
   1. Best Practice 3.00 3.00 2.85 3.15 
   2. Organization 3.04 3.00 2.90 3.18 
   3. Presentation 2.90 3.00 2.75 3.04 
   4. Specification 3.01 3.00 2.86 3.16 
   5. Worst Practice 2.90 3.00 2.75 3.05 
   6. Blank 3.05 3.00 2.91 3.19 
   7. Warning Label 2.98 3.00 2.83 3.13 
   Complete Sample 2.98 3.00 2.93 3.04 
Panel B – Legal Claim if We DO NOT Comply 
   1. Best Practice 3.61 4.00 3.47 3.75 
   2. Organization 3.57 4.00 3.44 3.70 
   3. Presentation 3.50 3.00 3.37 3.63 
   4. Specification 3.52 4.00 3.38 3.65 
   5. Worst Practice 3.49 4.00 3.35 3.64 
   6. Blank 3.73 4.00 3.61 3.85 
   7. Warning Label 3.54 4.00 3.40 3.67 
   Complete Sample 3.57 4.00 3.52 3.62 
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4.6. Attitudes About Our Survey 
 	  
 
 
 
 
Treatment Mean Median 90% Confidence Interval 
Panel A – Satisfied We Take Privacy Seriously 
   1. Best Practice 4.09 4.00 3.97 4.20 
   2. Organization 3.91 4.00 3.80 4.03 
   3. Presentation 3.99 4.00 3.87 4.12 
   4. Specification 4.02 4.00 3.89 4.14 
   5. Worst Practice 4.01 4.00 3.89 4.13 
   6. Blank 4.04 4.00 3.93 4.15 
   7. Warning Label 4.09 4.00 3.97 4.20 
   Complete Sample 4.02 4.00 3.98 4.06 
Panel B – Satisfied with our Survey 
   1. Best Practice 3.97 4.00 3.86 4.08 
   2. Organization 3.91 4.00 3.80 4.01 
   3. Presentation 3.87 4.00 3.76 3.99 
   4. Specification 3.95 4.00 3.83 4.06 
   5. Worst Practice 4.01 4.00 3.89 4.13 
   6. Blank 3.97 4.00 3.86 4.08 
   7. Warning Label 4.07 4.00 3.95 4.19 
   Complete Sample 3.96 4.00 3.92 4.01 
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5. ADDITIONAL ANALYSIS 
 
In addition to the primary results reported in the text of our paper, we also conducted 
three additional analyses. This part of our supplementary materials presents those results. 
First, we analyze the results for respondents that spent at least 30, 60, and 90 seconds on 
our initial disclosure screen. Second, we disaggregate our results for each our risky 
behavior and identifying information questions. Third, we present whether we were able 
to verify the zip codes that respondents self-reported.    
 
 
5.1. Results for “Readers” Only 
 
The median amount of time that our full sample spent on our privacy disclosures screens 
was 5.47 seconds. As we explain in Part 3.1.1 of the paper, it should take an average 
reader over 90 seconds to read even our shortest disclosure. Since the vast majority of our 
respondents spent so little time on our disclosure screens, we also subset our sample to 
just readers that spent at least 30, 60 and 90 seconds on the disclosure screen. The below 
table reports the number of respondents in each treatment group that met that criteria.  
 
 
# of Respondents That Remained on the Disclosure Screen by Time 
 
Treatment 
30  
Seconds 
60  
Seconds 
90 
Seconds 
1. Best Practice 17 6 4 
2. Organization 21 11 9 
3. Presentation 24 13 8 
4. Specification 22 9 4 
5. Worst Practice 23 12 5 
6. Blank 9 4 2 
7. Warning Label 17 5 4 
Complete Sample 133 60 36 
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The below table presents the average responses for each of our questions for respondents 
that spent at least 30, 60 and 90 seconds on the privacy disclosure screen. It also presents 
the average responses for respondents that were exposed the two most radical best 
practice techniques (the Best Practice treatment and the Warning Label Treatment).  
 
 
 
 
30  
Seconds 
60  
Seconds 
90 
Seconds 
1. Average Time on the Disclosure 103.16 178.14 249.06 
        - Best Practice 147.53 337.31 468.27 
        - Warning Label 129.35 343.80 409.32 
2. Correct Answers to Comp. Questions 1.56 1.48 1.25 
        - Best Practice 1.71 2.33 1.75 
        - Warning Label 2.65 2.20 2.00 
3. Risky Behaviors Disclosed 2.53 2.80 3.50 
        - Best Practice 2.12 2.67 2.25 
        - Warning Label 2.47 3.00 3.50 
4. Identifying Information Provided 2.62 2.50 2.83 
        - Best Practice 3.18 3.83 4.00 
        - Warning Label 2.24 2.00 1.75 
5.A. Legal Claims if We Comply 2.78 2.78 3.08 
        - Best Practice 2.94 3.33 3.5 
        - Warning Label 2.65 2.20 2.00 
5.B. Legal Claims if We Do Not Comply 3.55 3.83 3.58 
        - Best Practice 3.56 3.67 4.00 
        - Warning Label 3.76 3.00 3.00 
6.A. Satisfied we take Privacy Seriously 3.98 4.07 4.22 
        - Best Practice 4.12 4.67 4.00 
        - Warning Label 4.00 4.40 4.25 
6.B. Satisfied with our Survey 3.95 4.12 4.25 
        - Best Practice 4.06 4.17 4.00 
        - Warning Label 3.88 4.40 4.75 
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5.2. Sharing Personal Information – Breakdown of Results 
 
In Part 3.2.1 of the paper, we present the average number of 10 risky sexual behavior 
questions that respondents answered yes to. The tables below repeats those 10 questions 
and then present the average number of times respondents answered yes to each those 
questions by treatment groups.  
 
 
 
Questions on Risky Sexual Behavior 
1. Have you ever had sex with someone you met the same day? 
2. Have you ever had sex with someone you met the same day without using a condom? 
3. Have you ever cheated on your partner? 
4. Have you ever had anal sex? 
5. Have you ever had sexual thoughts about a member of your same sex? 
6. Have you ever used sex toys? 
7. Have you ever taken nude pictures of yourself or of a sexual partner? 
8. Have you ever been diagnosed with a sexually transmitted disease? 
9. Have you ever lied about how recently you were tests for STDS? 
10. Have you ever neglected to tell a partner about a sexually transmitted disease from 
which you were suffering?  
 
 
 
Proportion of “Yes” Response by Treatment Group  
 
Question 
(1) 
Best 
(2) 
Org. 
(3) 
Present. 
(4) 
Spec. 
(5) 
Worst 
(6)  
Blank 
(7) 
Warning 
 
Overall 
1 0.36 0.42 0.36 0.31 0.42 0.39 0.42 0.38 
2 0.25 0.32 0.30 0.25 0.32 0.26 0.29 0.28 
3 0.30 0.26 0.23 0.25 0.28 0.31 0.23 0.27 
4 0.36 0.42 0.38 0.36 0.44 0.40 0.33 0.38 
5 0.25 0.27 0.26 0.24 0.34 0.21 0.24 0.26 
6 0.51 0.55 0.49 0.45 0.50 0.49 0.47 0.50 
7 0.40 0.36 0.36 0.32 0.41 0.34 0.38 0.37 
8 0.14 0.11 0.11 0.12 0.13 0.11 0.07 0.11 
9 0.07 0.05 0.03 0.04 0.06 0.08 0.04 0.05 
10 0.06 0.04 0.03 0.06 0.04 0.05 0.04 0.05 
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In Part 3.2.2 of the paper, we present the average number of 5 identifying information 
questions that respondents provided an answer to. The tables below repeats those 5 
questions and then present the average number of times respondents provided 
information in response to each those questions by treatment groups.  
 
Questions Requesting Identifying Information 
1. In which county did you take this survey? 
2. What is the zip code where you took this survey? 
3. What is your phone number? 
4. What is your email address? 
5. What is your mailing address? 
 
 
 
Proportion of Information Provided by Treatment Group 
 
Question 
(1) 
Best 
(2) 
Org. 
(3) 
Present. 
(4) 
Spec. 
(5) 
Worst 
(6)  
Blank 
(7) 
Warning 
 
Overall 
1 0.77 0.86 0.79 0.84 0.79 0.82 0.89 0.82 
2 0.81 0.85 0.83 0.82 0.79 0.86 0.90 0.84 
3 0.23 0.15 0.21 0.24 0.24 0.21 0.26 0.22 
4 0.37 0.33 0.36 0.36 0.36 0.37 0.40 0.36 
5 0.27 0.21 0.27 0.33 0.25 0.23 0.26 0.26 
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5.3. Verification of Identifying Information 
 
One of the 5 pieces of identifying information that we requested from each respondent 
was their zip code. Since our survey software collected the IP addresses for the 
respondents that completed our survey, we are able to compare respondents self-reported 
zip code to the zip code collected by our survey software. It is important to note, 
however, that may respondents reported a zip code that was slightly different than the one 
identified by the survey software, possibly reporting genuine addresses that differed from 
the location in which they took the survey. As a result, we report both the proportion of 
respondents where all 5-digits of the zip code was verified, as well as respondents were 
the first 2 digits of their zip code was verified.  
 
 	  
 
 
 
 
 
% of Respondents Where Self-Reported Zip Code Matches IP Address 
Treatment 5 Digits 2 Digits 
1. Best Practice 0.33 0.86 
2. Organization 0.33 0.84 
3. Presentation 0.39 0.89 
4. Specification 0.31 0.82 
5. Worst Practice 0.33 0.82 
6. Blank 0.38 0.83 
7. Warning Label 0.26 0.83 
Complete Sample 0.33 0.84 
 
0.
2
0.
4
0.
6
0.
8
A. Zip Code Verified (5-Digit)
Treatment Group
M
ea
n
1. Best Practice 2. Organization 3. Presentation 4. Specification 5. Worst Practice 6. Blank 7. Warning Label
0.
2
0.
4
0.
6
0.
8
B. Zip Code V rified (2-Digits)
M
ea
n
1. Best Practice 2. Organization 3. Presentation 4. Specification 5. Worst Practice 6. Blank 7. Warning Label
	   30 
6. PRELIMINARY SURVEY 
 
Creating the “Warning Label” treatment required identifying which of the 12 substantive 
policies in our privacy disclosure were the “most unexpected.” To determine which 5 
policies were the most unexpected, we sent a link to a preliminary survey to our 
colleagues and students. The survey presented each of the 12 substantive policies from 
our privacy disclosure in random order, and asked respondents to say how unexpected 
they policy would be on a 7-point scale from “Strongly Expected” (coded as 1) to 
“Strongly Unexpected” (coded as 7). This section presents: (1) the wording of the request 
that we sent and (2) the results of the preliminary survey.  
 
 
6.1. Preliminary Survey – Wording of the Request 
 
 
We are currently researching how privacy notices influence willingness of users to 
disclose personal information on websites.  
 
As part of the project, we are conducting a survey experiment that tells respondents that 
we are developing a commercial dating app, and ask them for information on their sexual 
practices and to provide their contact information. The experimental treatment is that, 
before completing the survey, the respondents are provided with different versions of 
disclosure that outlines our privacy practices. 
 
One of the things we are testing is whether a reduced-form "nutrition label" style 
disclosure is more effective than a complete disclosure. In order to develop that reduced 
disclosure, we have to identify which aspects of our privacy disclosure are the most 
"unexpected."  
 
In this short survey, we would like you to look at the 12 practices contained in the 
privacy disclosure we have developed. These are the things the company allegedly does 
with the respondents information. We would then like you to place each item on a scale 
from "strong unexpected" to "strongly expected" based on what you would expect for a 
survey on sexual practices being conducted by a corporation. 
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6.2. Preliminary Survey – Results 
 
The following Table Presents the average score each policy was given on a 7-point scale 
from “Strongly Expected” (coded as 1) to “Strongly Unexpected” (coded as 7). The 5 
policies with the highest score were then used in the Warning Label treatment.  
 
 
Substantive Policies Mean 
Score 
Rank 
The Information We Collect   
• We collect information on your sexual practices based on 
your responses to questions in this survey.  
2.73 9 
• We collect personal information that can identify you 
through this online interaction with your computer. 
3.60 3 
• We collect and link additional information about you from 
other public and private data sources. 
4.27 2 
How We Use the Information    
• We use the information for commercial development of a 
dating application for smartphones. 
2.73 9 
• We use the information to develop advertising and 
marketing tools within the application. 
2.10 12 
• We use the information to follow up with you on future 
communications. 
2.17 11 
Disclosure of Data to Third Parties   
• We share the information with commercial partners to 
improve the commercial utility of the application. 
2.85 8 
• We share the data with advertisers and ad-placement 
companies that help us design the profit opportunities from 
the mobile application. 
3.02 7 
• We share the data with commercial health insurance 
companies that partner with us in developing the data-
driven application.  
4.83 1 
Protection of Personal Information   
• We retain the information indefinitely. 
 
3.54 4 
• We save your personal information on cloud server with 
limited access.  
2.15 6 
• We encourage our partners to take high security measures 
in storing your data, but we are unable to verify their 
security practices. 
3.51 5 
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7. PILOT SURVEY 
 
We initially conducted a pilot survey during the week of October 12, 2015. The pilot 
survey was administered to respondents recruited through Amazon’s Mechanical Turk 
platform. The survey for the pilot used a slightly modified framing and set of privacy 
disclosures. The results of that pilot were presented at the Contracting Over Privacy 
conference held at the University of Chicago Law School on October 16-17, 2015. This 
section presents information on the pilot’s: (A) Framing; (B) Privacy Disclosures; (C) 
Sample; and (D) Results.  
 
 
7.1. Pilot Survey – Framing  
 
Our pilot survey was framed as research being conducted to halt the spread of sexually 
transmitted diseases. The respondents were given this information in during the opening 
screen of the survey. That screen presented the following information: 
 
Purpose of the Survey 
 
This survey is conducted by a research group in Chicago developing a new medical 
treatment for sexually transmitted diseases. The research examines risky sexual behavior. 
The results will be used to design programs to help halt the spread of sexually transmitted 
disease. It is important that you answer all questions honestly.   
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7.2. Pilot Survey – Privacy Disclosures 
 
7.2.1. Best Practice Disclosure 
 
Your Privacy Rights 
 
We value your privacy. In this page, we explain our data privacy practices. We explain how we collect, use, disclose, transfer, and 
store the information about you that you reveal in the survey. Continuing past this page means that you grant us permission to engage 
in these practices, including the permission to share the information with others as explained below. 
 
 
The Information We Collect 
 
• We collect information on your sexual practices based on your responses to questions in this survey.  
For Example: In the survey, you will be asked how your sexual behavior is affected by risks of transmitted diseases. You do 
not have to provide responses, but if you do we collect your answers. 
 
• We collect personal information that can identify you through this online interaction with your computer. 
For Example, we collect information about your IP address, geographical location, zip code, the type of computer you use 
in this survey.  
 
• We collect additional information about you from other public and private data sources. 
For Example, we collect information about you from social media sites and insurance databases. 
 
 
How We Use the Information  
 
• We use the information for academic research. 
For Example, we use statistical tools to measure the potential effectiveness of the medical treatments we are developing. 
 
• We use the information to develop future medical treatments. 
For Example, we develop medical treatments that depend on each patient’s personal medical history. 
 
• We use the information to follow up with you on future communications. 
For Example, we might send you offers to access to our new medical treatments. We will also communicated with you if 
there are changes to this Privacy Policy. 
 
Disclosure of Data to Third Parties 
 
• We share the information with research partners to improve the accuracy of our findings. 
For Example, we share the information with an outside research companies that performs some analysis for us and with 
other researchers in academic institutions that study sexually transmitted diseases. 
 
• We share the data with our partners that work with us on developing a new medical treatment and making it available for 
patients. 
For example, we disclose the information to iMed Solutions, Inc., a commercial company affiliated with our study that is 
developing personalized medical treatments. iMed Solutions, Inc.,  may further share the information with its affiliates and 
partners or sell it to others.  
 
• We share the data with insurance companies that partner with us in developing the new medical treatment. 
For Example, we disclose the information to MHM Company (Midwestern Health Mutual Company), a health insurance 
company specializing in personalized health policies. MHI may share the information with its affiliates and partners, 
beyond our control, and use it for the development of its health insurance business. 
 
These disclosures of your data and personal information may be done without requesting additional consent from you. Additional 
disclosures of you information to government agencies will be made to the extent permitted or required by law. 
 
Protection of Personal Information 
 
• We keep the personal information protected. 
For Example, files containing your personal information will be locked at specially designated file cabinet in our office. 
 
• We secure any communication that contains your personal information. 
For Example, we encrypt any files containing personal information when we share or transmit them among our research 
and commercial partners. 
 
• We hold our research partners to equally high data security standards. 
For Example, we request that any of our partners receiving your personal information protect it by password. 
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7.2.2. Organization Disclosure 
 
Your Privacy Rights 
	  
We value your privacy. In this page, we explain our data privacy practices. We explain how we collect, use, disclose, transfer, and 
store the information about you that you reveal in the survey or in any other interaction, transaction, or engagement that links, 
references, or presents this policy. Continuing past this page means that you grant us permission to engage in these practices, 
including the permission to share the information with others as explained below. 
 
This policy covers the survey as well as any interactions you may have with us. When you review this survey, please keep in mind that 
it is intended for a U.S. audience and the information may processed or transferred in the United States. Our survey is not intended for 
children under 13. We do not knowingly collect personal information from children under 13. If you have any relation with the survey 
group and any of its affiliates, we may collect information about you. If you have any questions after reviewing this policy, please 
address them according to the direction provided below.  
 
We collect information on your sexual practices based on your responses to questions in this survey. You do not have to provide 
responses, but any response you provide is collected and stored. This includes information about sexual behavior in the present and in 
the past, how your behavior is affected by risks including risks of sexually transmitted diseases, and other information related to 
sexual conduct that you provide us. For Example, in the survey you will be asked how your sexual behavior is affected by risks of 
transmitted diseases. You do not have to provide responses, but if you do we collect your answers. We also collect personal 
information that can identify you, including but not limited to your location information, the type of device you are using to respond to 
this survey, the web browser software, and the IP address of your computer. This information is collected through this online 
interaction with your computer and is intended to customize in a statistical and automated manner your profile. For Example, we 
collect information about your IP address, geographical location, zip code, the type of computer you use in this survey. In addition, we 
may collect and supplement or substitute the personal information collected through this online transaction with additional personal 
and non-personal information available from affiliated entities, research partners, and other independent third-party sources. These 
include but are not limited to social media sites, public and private databases, and insurance records, all in accordance with these 
providers’ policies. We acquire information from other trusted sources to update or supplement the information you provided or we 
collected automatically. Local law may require that you authorize the third party to share your information with us before we can 
acquire it. We may also collect other personal information when you provide such information or where we believe it is reasonably 
required for ordinary completion of the research that is part of this study. For Example, we collect information about you from social 
media sites and insurance databases. 
 
We use the information for academic research, operating and improving our line of research, including the development of new 
products and services, the improvement of existing products and services, the performance of data analytics, and other internal 
function. For Example, we use statistical tools to measure the potential effectiveness of the medical treatments we are developing. The 
main use of the information is in developing a new medical treatment for sexually transmitted diseases. The research examines risky 
sexual behavior. The results will be used to design programs to help halt the spread of sexually transmitted diseases.  We employ 
statistical tools in the analysis of the answers we receive from you and other survey subjects to measure the potential effectiveness of 
the medical treatments we are developing. We also use the information to develop future medical treatments in partnership with our 
research affiliates. The medical treatments we are developing are personalized, which means that they depend on each patient’s 
personal medical history.  We also use the information in complying with and enforcing applicable legal requirements, relevant 
industry standards, contractual obligations and our policies; and for any other purposes that we may specifically disclose at the time 
you provide or we collect your information. We may also use data that we collect on an aggregate or anonymous basis (such that it 
does not identify any individual respondent) for various research purposes, where permissible under applicable laws and regulations. 
For Example, we develop medical treatments that depend on each patient’s personal medical history. Finally, we use the information 
to follow up with you on future communications, and we might send you offers to access to our new medical treatments. We will also 
communicated with you if there are changes to this Privacy Policy. For Example, we might send you offers to access to our new 
medical treatments. We will also communicated with you if there are changes to this Privacy Policy. 
 
We share the information we collect from and about you with our affiliates and other third parties. We share some of the information 
with research partners to improve the accuracy of our findings, to help us perform some of the analytics of this study, and to 
collaborate with researchers that study related topics. For Example, we share the information with an outside research companies that 
performs some analysis for us and with other researchers in academic institutions that study sexually transmitted diseases. We also 
share the data with our partners that work with us on developing a new medical treatment and making it available for patients, which 
includes companies that offer commercial services, products, or programs in the area of personalized medical treatments, and affiliates 
and partners of such companies. For example, we disclose the information to iMed Solutions, Inc., a commercial company affiliated 
with our study that is developing personalized medical treatments. iMed Solutions, Inc.,  may further share the information with its 
affiliates and partners or sell it to others. We also share the data with insurance companies that partner with us in developing the new 
medical treatment, including companies specializing in health and wellness, and affiliates and partners of such companies. Where 
appropriate, we will limit sharing of your information in accordance with the policies specified in this notice and in accordance with 
applicable laws and regulations, industry practices, and contractual obligations.. These disclosures of your data and personal 
information may be done without requesting additional consent from you. Additional disclosures of you information to government 
agencies will be made to the extent permitted or required by law. For Example, we disclose the information to MHM Company 
(Midwestern Health Mutual Company), a health insurance company specializing in personalized health policies. MHI may share the 
information with its affiliates and partners, beyond our control, and use it for the development of its health insurance business. 
 
Residents of Vermont: We will not share personally identifiable information unless authorized by you. This does not limit us from 
sharing certain information about your response to the survey as permitted by law.  
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We want you to feel confident about using this website to respond to the survey, and we are committed to protecting the information 
we collect. While no online platform can guarantee security, we have implemented appropriate administrative, technical, and physical 
security procedures to help protect the personal information you provide to us. We use reasonable physical, electronic, and procedural 
safeguards that comply with safety standards to protect and limit access to personal information. This includes device safeguards and 
secured files and buildings. For Example, files containing your personal information will be locked at specially designated file cabinet 
in our office. We lock the information in secure locations, and require our partners and affiliates to do the same and to password 
protect the files when necessary. For Example, we request that any of our partners receiving your personal information protect it by 
password. When we transmit the information, we encrypt any files containing personal information, and we employ firewalls and 
intrusion detection systems to help prevent unauthorized persons from gaining access to your information. For Example, we encrypt 
any files containing personal information when we share or transmit them among our research and commercial partners protect it by 
password. 
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7.2.3. Presentation Disclosure 
 
Your Privacy Rights 
 
Your privacy is valued by us. In this page, our data privacy practices are explained. It is explained how we collect, use, disclose, 
transfer, and store the information about that is being revealed by you in the survey. Continuing past this page means that permission 
to engage in these practices is granted to us, including the permission to share the information with others, as explained below. 
 
 
The Information We Collect 
 
• Based on your responses to questions in this survey, information on your sexual practices will be collected by us.  
For Example: In the survey, you will be asked how your sexual behavior is affected by risks of transmitted diseases. 
Responses do not have to provided by you, but if the are, they will be collected by us. 
 
• Through this online interaction with your computer, personal information that can identify you will be collected by us.  
For Example, information about your IP address, geographical location, zip code, the type of computer being uses in this 
survey is collected.  
 
• Additionally, from other public and private data sources, personal information that can identify you will be collected by us.  
For Example, information about you from social media sites and insurance databases may be collected. 
 
 
How We Use the Information  
 
• Academic research is how your the information will be used by us. 
For Example, statistical tools to analyze the information and to measure the potential effectiveness of the medical 
treatments we are developing will be used. 
 
• Developing future medical treatments is another way that the information will be used by us. 
For Example, medical treatments that depend on each patient’s personal medical history are being developed. 
 
• To follow up with you on future communications is another way that your information may be used by us.  
For Example, offers to access to our new medical treatments may be sent to you. Also, changes to this Privacy Policy will 
be communicated. 
 
Disclosure of Data to Third Parties 
 
• To improve the accuracy of our findings, the information will be shared by us with research partners.  
For Example, information will be shared with an outside research companies that performs some analysis for us and with 
other researchers in academic institutions that study sexually transmitted diseases. 
 
• Our partners that work with us on developing a new medical treatment and making it available for patients will have the data 
shared with by us. 
For example, information will be disclosed to iMed Solutions, Inc., a commercial company affiliated with our study that is 
developing personalized medical treatments. iMed Solutions, Inc.,  may further share the information with its affiliates and 
partners or sell it to others.  
 
• Insurance companies that partner with us in developing the new medical treatment will have the data shared with by us. 
For Example, information will be disclosed to MHM Company (Midwestern Health Mutual Company), a health insurance 
company specializing in personalized health policies. MHI may share the information with its affiliates and partners, 
beyond our control, and use it for the development of its health insurance business. 
 
These disclosures of your data and personal information may be done without requesting additional consent from you. Additional 
disclosures of you information to government agencies will be made to the extent permitted or required by law. 
 
Protection of Personal Information 
 
• Your personal information will be protected by us.  
For Example, files containing your personal information will be locked at specially designated file cabinet in our office. 
 
• Any communication that contains your personal information will be secured by us. 
For Example, any files containing personal information will be encrypted when we share or transmit them among our 
research and commercial partners. 
 
• Our research partners will be held to to equally high data security standards by us. 
For Example, any of our partners receiving your personal information will be requested to protect it by password. 
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7.2.4. Specification Disclosure 
 
Your Privacy Rights 
 
We value your privacy. In this page, we explain our data privacy practices. We explain how we collect, use, disclose, transfer, and 
store the information about you that you reveal in the survey. Continuing past this page means that you grant us permission to engage 
in these practices, including the permission to share the information with others as explained below. 
 
The Information We Collect 
 
• We collect information on your sexual practices based on your responses to questions in this survey. You do not have to provide 
responses, but any response you provide is collected and stored. 
 
• We collect personal information that can identify through this online interaction with your computer. This information is 
collected through this online interaction with your computer and is intended to customize in a statistical and automated manner 
your profile. 
 
• We collect additional information about you from other public and private data sources. We may collect and supplement or 
substitute the personal information collected through this online transaction with additional personal and non-personal 
information available from affiliated entities, research partners, and other independent third-party sources. 
 
How We Use the Information  
 
• We use the information for academic research, operating and improving our line of research, including the development of new 
products and services, the improvement of existing products and services, the performance of data analytics, and other internal 
functions. 
 
• We use the information to develop future medical treatments. We employ statistical tools in the analysis of the answers we 
receive from you and other survey subjects to measure the potential effectiveness of the medical treatments we are developing. 
 
• We use the information to follow up with you on future communications. We use the information to follow up with you on 
future communications, and we might send you offers to access to our new medical treatments. 
 
 
Disclosure of Data to Third Parties 
 
• We share the information with research partners to improve the accuracy of our findings. We share some of the information with 
research partners to improve the accuracy of our findings, to help us perform some of the analytics of this study, and to 
collaborate with researchers that study related topics. 
 
• We share the data with our partners that work with us on developing a new medical treatment and making it available for 
patients. This includes companies that offer commercial services, products, or programs in the area of personalized medical 
treatments, and affiliates and partners of such companies. 
 
• We also share the data with insurance companies that partner with us in developing the new medical treatment, including 
companies specializing in health and wellness, and affiliates and partners of such companies. 
 
These disclosures of your data and personal information may be done without requesting additional consent from you. Additional 
disclosures of you information to government agencies will be made to the extent permitted or required by law. 
 
Protection of Personal Information 
 
• We keep the personal information protected. We use reasonable physical, electronic, and procedural safeguards that comply with 
safety standards to protect and limit access to personal information. 
 
• We secure any communication that contains your personal information. When we transmit the information, we encrypt any files 
containing personal information, and we employ firewalls and intrusion detection systems to help prevent unauthorized persons 
from gaining access to your information. 
 
• We hold our research partners to equally high data security standards. We require our partners and affiliates to implement the 
same high data security standards that we do. 
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7.2.5. Worst Practice 
 
Your Privacy Rights 
	  
Your privacy is valued by us. In this page, our data privacy practices are explained. It is explained how we collect, use, disclose, 
transfer, and store the information about you that is being revealed by you in the survey or in any other interaction, transaction, or 
engagement that links, references, or presents this policy. Continuing past this page means that permission to engage in these 
practices is granted to us, including the permission to share the information with others as explained below. 
 
This policy covers the survey as well as any interactions you may have with us. When this survey is being reviewed by, please keep in 
mind that it is intended for a U.S. audience and the information may be processed or transferred in the United States. Our survey is 
not intended for children under 13. Personal information from children under 13 is not knowingly collected by us. If you have any 
relation with the survey group and any of its affiliates, we may collect information about you. If you have any questions after 
reviewing this policy, have them addressed according to the direction provided below.  
 
Information on your sexual practices based on your responses to questions in this survey will be collected by us. Responses do not 
have to be provided, but any response that is provided is collected and stored. This includes information about sexual behavior in the 
present and in the past, how your behavior is affected by risks including risks of sexually transmitted diseases, and other information 
related to sexual conduct that you provide us. Also collected is personal information that can identify you, including but not limited to 
your location information, the type of device you are using to respond to this survey, the web browser software, and the IP address of 
your computer. This information is collected through this online interaction with your computer and is intended to customize in a 
statistical and automated manner your profile. In addition, the personal information collected through this online transaction with 
additional may be supplemented or substituted with personal and non-personal information available from affiliated entities, research 
partners, and other independent third-party sources. These include but are not limited to social media sites, public and private 
databases, and insurance records, all in accordance with these providers’ policies. In addition, information from other trusted 
sources is acquired to update or supplement the information you provided or that is collected automatically. Local law may require 
that you authorize the third party to share your information with us before we can acquire it. Other personal information may be 
collected when you provide such information or where we believe it is reasonably required for ordinary completion of the research 
that is part of this study. 
 
Your information will be used by us for academic research and for operating and improving our line of research, including the 
development of new products and services, the improvement of existing products and services, the performance of data analytics, and 
other internal functions. The main use of the information is in developing a new medical treatment for sexually transmitted diseases. 
The research examines risky sexual behavior. The results will be used to design programs to help halt the spread of sexually 
transmitted diseases.  Statistical tools in the analysis of the answers we receive from you and other survey subjects will be employed to 
measure the potential effectiveness of the medical treatments we are developing. The information will also be used to develop future 
medical treatments in partnership with our research affiliates. The medical treatments that are being developed are personalized, 
which means that they depend on each patient’s personal medical history. The information is also used in complying with and 
enforcing applicable legal requirements, relevant industry standards, contractual obligations and our policies; and for any other 
purposes that would be specifically disclosed at the time you provide or we collect your information. The information that is being 
collected may also be used on an aggregate or anonymous basis (such that it does not identify any individual respondent) for various 
research purposes, where permissible under applicable laws and regulations. Finally, the information is used to follow up with you on 
future communications, and offers to access to our new medical treatments might be sent to you. If there are changes to this Privacy 
Policy, they will be communicated to you.  
 
To improve the accuracy of our findings the information will be shared by us with research partners. Some of the information is 
shared with research partners to improve the accuracy of our findings, to help us perform some of the analytics of this study, and to 
collaborate with researchers that study related topics. The data is also shared with our partners that work with us on developing a 
new medical treatment and making it available for patients, which includes companies that offer commercial services, products, or 
programs in the area of personalized medical treatments, and affiliates and partners of such companies. The data is also shared with 
insurance companies that partner with us in developing the new medical treatment, including companies specializing in health and 
wellness, and affiliates and partners of such companies. Where appropriate, sharing of your information will be limited in accordance 
with the policies specified in this notice and in accordance with applicable laws and regulations, industry practices, and contractual 
obligations.. These disclosures of your data and personal information may be done without requesting additional consent from you. 
Additional disclosures of you information to government agencies will be made to the extent permitted or required by law. 
 
Residents of Vermont: Unless authorized by you, personally identifiable information will not be shared by us. This does not limit us 
from sharing certain information about your response to the survey as permitted by law.  
 
We want you to feel confident about using this website to respond to the survey and we are committed to protecting the information 
being collected by us. While no online platform can guarantee security, appropriate administrative, technical, and physical security 
procedures have been implemented by us to help protect the personal information that is being provided to us. Reasonable physical, 
electronic, and procedural safeguards that comply with safety standards are used to protect and limit access to personal information. 
This includes device safeguards and secured files and buildings. Your information is locked in secure locations, and our partners and 
affiliates are required to do the same and to have the files password protected when necessary. When the information is being 
transmitted, any files containing personal information are encrypted, and firewalls and intrusion detection systems are employed to 
help prevent unauthorized persons from gaining access to your information.	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7.3. Pilot Survey – Sample  
 
We recruited 767 respondents to take our survey through Amazon’s Mechanical Turk 
(mTurk) service. mTurk is a service that pays individuals a small fee for completing short 
tasks. The tables bellow provide the demographic breakdown of our sample compared the 
adult population of the United States and the number of treatments that received each 
treatment.  
 
Demographic Characteristics of the Sample for the Pilot Survey 
 #  
in Pilot 
%  
of Pilot  
% of U.S. 
Population 
Gender    
Male 440 57% 48% 
Female 327 43% 52% 
Age    
18-24 136 18% 13% 
25-34 378 49% 18% 
35-44 146 19% 18% 
45-54 72 9% 19% 
55-64 28 4% 16% 
65+ 7 1% 17% 
Race/Ethnicity    
White 613 80% 69% 
Hispanic 32 4% 14% 
Black 52 7% 11% 
Asian 5 1% 4% 
Other 8 1% 2% 
Region    
Northeast 148 19% 18% 
Midwest 167 22% 22% 
South 264 34% 37% 
West 188 25% 23% 
 
Number of Respondents by Treatment 
Treatment Respondents 
1. Best Practice 123 
2. Organization 139 
3. Presentation 124 
4. Specification 134 
5. Worst Practice 143 
6. Control 104 
Complete Sample 767 
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7.4. Pilot Survey – Results 
 
7.4.1. Time Spent on the Disclosure 
 
 
 
 
 
Treatment Mean Median 90% Confidence Interval 
1. Best Practice 11.62 4.07 7.25 15.98 
2. Organization 22.68 4.78 13.50 31.86 
3. Presentation 10.59 4.50 7.84 13.34 
4. Specification 10.03 2.90 7.16 12.91 
5. Worst Practice 8.38 3.35 6.12 10.65 
6. Control 9.27 4.86 5.95 12.59 
Complete Sample 12.53 4.08 10.23 14.29 
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7.4.2. Number of Correct Answers 
 
 
 
 
 
 
 
Treatment Mean Median 90% Confidence Interval 
1. Best Practice 1.54 1.00 1.39 1.69 
2. Organization 1.25 1.00 1.13 1.37 
3. Presentation 1.50 1.00 1.36 1.64 
4. Specification 1.35 1.00 1.24 1.46 
5. Worst Practice 1.23 1.00 1.11 1.35 
6. Control 2.66 3.00 2.37 2.96 
Complete Sample 1.54 1.00 1.47 1.61 
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7.4.3. Risky Behaviors 
 
 
 
 
 
 
 
Treatment Mean Median 90% Confidence Interval 
1. Best Practice 3.22 3.00 2.89 3.55 
2. Organization 3.07 3.00 2.77 3.38 
3. Presentation 3.23 3.00 2.91 3.57 
4. Specification 3.73 4.00 3.41 4.05 
5. Worst Practice 3.77 4.00 3.45 4.08 
6. Control 3.15 3.00 2.81 3.50 
Complete Sample 3.38 3.00 2.25 3.51 
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7.4.4. Personal Information Provided 
 
 
 
 
 
 
 
Treatment Mean Median 90% Confidence Interval 
1. Best Practice 1.22 1.00 1.06 1.38 
2. Organization 1.21 1.00 1.06 1.36 
3. Presentation 1.35 1.00 1.18 1.53 
4. Specification 1.43 1.00 1.27 1.59 
5. Worst Practice 1.28 1.00 1.11 1.45 
6. Control 1.19 1.00 0.99 1.39 
Complete Sample 1.28 1.00 1.22 1.35 
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7.4.5. Certainty About Legal Claims 
 
 
 
 
 
Treatment Mean Median 90% Confidence Interval 
Panel A – Legal Claim if We Comply 
   1. Best Practice 2.54 2.00 2.38 2.71 
   2. Organization 2.47 2.00 2.32 3.63 
   3. Presentation 2.40 2.00 2.24 2.56 
   4. Specification 2.54 2.00 2.39 2.70 
   5. Worst Practice 2.43 2.00 2.28 2.59 
   6. Control 2.54 2.00 2.36 2.71 
   Complete Sample 2.49 2.00 2.42 2.55 
Panel B – Legal Claim if We DO NOT Comply 
   1. Best Practice 3.71 4.00 3.53 3.88 
   2. Organization 3.67 4.00 3.52 3.82 
   3. Presentation 3.66 4.00 3.50 3.83 
   4. Specification 3.57 4.00 3.39 3.75 
   5. Worst Practice 3.87 4.00 3.72 4.01 
   6. Control 3.55 4.00 3.34 3.75 
   Complete Sample 3.68 4.00 3.61 3.74 
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7.4.6. Attitudes About Our Survey 
 
 
 
 
Treatment Mean Median 90% Confidence Interval 
Panel A – Satisfied We Take Privacy Seriously 
   1. Best Practice 3.79 4.00 3.64 3.94 
   2. Organization 3.63 4.00 3.48 3.78 
   3. Presentation 3.86 4.00 3.72 4.01 
   4. Specification 3.60 4.00 3.43 3.76 
   5. Worst Practice 3.91 4.00 3.77 4.04 
   6. Control 3.83 4.00 3.67 3.98 
   Complete Sample 3.77 4.00 3.71 3.83 
Panel B – Satisfied with our Survey 
   1. Best Practice 4.06 4.00 3.93 4.19 
   2. Organization 3.83 4.00 3.70 3.97 
   3. Presentation 3.96 4.00 3.82 4.10 
   4. Specification 3.89 4.00 3.74 4.04 
   5. Worst Practice 4.06 4.00 3.93 4.20 
   6. Control 3.96 4.00 3.81 4.11 
   Complete Sample 3.96 4.00 3.90 4.02 
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